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Resumo Na última década do século XX verificaram-se progressos 
notáveis dos substituintes de sangue de 1ª geração. As emulsões 
à base de perfluorocarbonetos (PFCs) são neste momento os 
candidatos que apresentam maior fiabilidade e segurança como 
substituintes artificiais do sangue. O principal objectivo do 
presente trabalho é o estudo dos líquidos iónicos fluorados 
(FILs), de forma a que passem a substituir total ou parcialmente 
os PFCs atualmente usados como substituintes artificiais do 
sangue, de forma a desenvolver novas emulsões com 
propriedades avançadas. 
Com este objectivo, efectouou-se a caracterização termofísica  e 
termodinâmica de diversos FILs, de forma a selecionar o FIL 
mais apropriado para a aplicação proposta. A caracterização 
envolve a medição experimental e análise da temperatura de 
decomposição e de fusão, densidade, viscosidade, índice de 
refracção e condutividade iónica, à pressão atmosférica num 
intervalo de temperatura entre 298.15 e 353.15 K. Foi também 
estudado o equilíbrio líquido-líquido das misturas binárias PFCs 
e FILs, à pressão atmosférica num intervalo de temperaturas 
geralmente entre 293.15 e 353.15 K. O conhecimento do 
comportamento de fase é crucial para a reformulação das 
emulsões usadas atualmente como terapêuticas de oxigénio. 
Finalmente, foi aplicado com sucesso o modelo termodinâmico 
Non-Random Two Liquid (NRTL), de forma a poder 
correlacionar o comportamento das misturas binárias de PFCs e 
FILs. 
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Abstract The last decade of the 20th century has yielded a remarkable 
progress in the field of first generation artificial blood 
substitutes. Emulsions based on perfluorocarbons (PFCs) 
became one of the main candidates for a safe and reliable 
artificial blood substitute. The final objective of the present 
work is to study the fluorinated ionic liquids (FILs) with the 
purpose of replacing, partially or totally, the PFCs actually 
used as artificial blood substitutes, thus providing new fluids 
with tailored advanced properties.  
With this goal in mind, the thermophysical and thermodynamic 
characterization of several FILs, was carried out with the aim 
to select the most appropriate candidate. This characterization 
involves the measurement and analysis of the decomposition 
and melting temperature, density, viscosity, refractive index, 
and ionic conductivity at atmospheric pressure in a temperature 
range from 298.15 to 353.15 K. Furthermore, the liquid-liquid 
equilibria of binary mixtures of PFCs and FILs were studied, at 
atmospheric pressure in a temperature range usually from 
293.15 to 343.15 K. The knowledge of the phase behaviour is 
crucial to the formulation of emulsions used nowadays as 
suitable oxygen carriers. Finally, Non-Random Two Liquid 
(NRTL) thermodynamic model was successfully applied to 
correlate the behaviour of the binary mixtures of PFCs and 
FILs 
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General Introduction 
  29 
1.1 General Context 
 
The transport and delivery of oxygen in vivo by other means than the red blood cells has 
become one of the most challenging research topics of the last 25 years [1]. Considering its 
undeniable value in procedures that imply blood loss, different substitutes have been developed so 
far. The first generation of artificial oxygen carriers, often referred as oxygen therapeutics, is now 
reaching the critical phase of trials. Taking into account its reliability, emulsions based on 
perfluorocarbons (PFCs) are currently among the preferred artificial blood candidates. 
The final goal of this thesis is to give the first step into the development of a new and 
improved generation of oxygen therapeutics using fluorinated ionic liquids (FILs). In particular, 
the partial or total replacement of the PFCs currently used in the emulsions for oxygen 
therapeutics by FILs will be addressed since several advantages, such as enhancement of 
respiratory gas solubility and emulsion stability and lowering of vapour pressure, are envisaged. 
The feasibility of this proposal will be evaluated through the study of the thermodynamic 
properties and phase equilibria of pure FILs and mixtures with FIL. 
The benefits for the society of a safe blood substitute that could be administered 
disregarding the recipient’s blood type are enormous, not to mention the prolonged shelf live 
under a wide range of temperatures. Everyday there is a large demand for blood to replace acute 
blood loss in accident victims and surgical patients needing short term replenishment of blood’s 
oxygen carrying capacity. 
The innovative results of this thesis are expected to raise new relevant questions in the ionic 
liquids community. Furthermore, the nearly null volatility of ionic liquids, its easy recovery and 
therefore, recyclability completely justify the development of this research work, particularly 
given the undeniably important objective of improving the available oxygen therapeutics. 
 
1.2 Oxygen therapeutics 
 
Oxygen carriers are responsible for the transport of the respiratory gases (oxygen and 
carbon dioxide) for a limited period of time during clinical applications [2] such as in the 
management of operative blood loss, trauma, acute normovolemic hemodilution, traumatic brain 
injury, and blood requirements in patients who refuse or have contraindications to transfusions of 
red blood cells. Although the designation of “blood substitutes” is frequently used, it can be 
misleading [1] since it implies that these products can totally replace all the functions of blood 
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(such as immunity, coagulation etc), which is not the case. These fluids only have the function to 
transport oxygen to the cells and carbon dioxide from the cells to the lungs. 
There are two classes of oxygen therapeutics based on the transport mechanism: 
perfluorocarbon-based, where oxygen is physically dissolved in the carrier, and hemoglobin-
based, where oxygen is chemically bounded to the carrier. The use of the hemoglobin-based as 
oxygen therapeutic emerged over a century ago [3] and since the first results were disappointing, 
PFC-emulsions were proposed as an alternative to deliver oxygen in vivo.  
Then, Hemoglobin-based oxygen therapeutics have been derived from human, animal, or 
recombinant hemoglobin and have involved an impressive diversity of structural modifications 
and formulations. The modifications are made accordingly to physiological characteristics and are 
most important to the indication pursued [3]. The final products are eventually formulated as 
solutions, capsules or suspensions of liposome. The hemoglobin concentration ranges have 
limitations due to colloidal osmotic pressure, viscosity or encapsulation efficiency. Each product 
has its own unique oxygen delivery characteristics and physiological responses [3].  
Due to their immiscibility in water, the PFCs are formulated as emulsions for intravascular 
administration. In these emulsions, the PFCs are coated with a thin layer of a surfactant that 
serves as an emulsifier and a stabilizer [4]. The emulsifier most used in the PFC emulsions is egg 
yolk phospholipids (EYP) and typically, fluorocarbon emulsion droplet sizes [4] are in the 0.1-0.2 
µm range (30-70 times smaller than the red blood cells). These droplets will fill the gaps present 
in the plasma between red cells that are found in microcirculation. The PFC particles provide a 
strong driving force for diffusion of oxygen to the tissues [5]. Therefore, a great effectiveness of 
PFC-based emulsions in capillary bed and at low hematocrits is expected.  
Afterwards, it was discovered that perfluorodecalin is excreted from the body much more 
rapidly than previously investigated [6-8], allowing for the first commercial emulsion, Fluosol 
[8], which became the first injectable oxygen carrier to be approved by the American Food and 
Drug Administration (FDA). The emulsion received regulatory approval in the USA and Europe 
in the period 1989-1990 for clinical use as an oxygen-carrier [9-11]. However, the cardiologists 
did not adopt Fluosol because improvements in angioplasty technology made its use redundant 
and its manufacture was terminated in 1994. The principal limitations of this first PFC-based 
emulsion were: the need to store frozen, the need to defrost and re-constitute before use and the 
main disadvantage, its poor efficacy as an oxygen carrier [10, 11]. Other PFC-emulsions of first 
generation include Perftotran [12] and Oxypherol [11]. 
The objectives of the second generation of PFC emulsions were to use highly purified PFCs 
with biocompatibility and excretion properties acceptable for in vivo use, to improve stability 
characteristics and hence shelf-life and to develop concentrated emulsions having significantly 
increased PFC content and thus conferring superior oxygen-carrying capacity [11]. However, one 
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of the biggest problems found for concentrated PFC emulsions with increased oxygen-carrying 
potential, was their high viscosities which prevented their use in vasculature. The second-
generation emulsions were essentially based on perflubron (bromoperfluoro-n-octane) or 
perfluorodecalin and have been stabilized avoiding molecular diffusion using small quantities of 
an appropriate high boiling point oil (HBPO) [3]. The second generation of perfluorocarbon 
emulsions (Oxigent, Oxyfluor, TherOx, among others) was less sensitive to processing 
parameters, easier to sterilize and also displayed better resistance to mechanical stress. Oxigent 
presented a shelf-life of at least 24 months, when stored at 278-283 K, and had a viscosity close to 
that of the blood, contributing to the maintenance of normal hemodynamics. However, TherOx 
[13] had a shelf-life of 1 year at 277 K. Sustained efforts have subsequently led to more advanced 
second generation products that are now in clinical trials [4]. The composition and characteristics 
of injectable PFC emulsion are shown in Table 1.1. 
 
Table 1.1 – Composition and characteristics of injectable PFC emulsion oxygen carriers [4]. 
Emulsion Perfluorocarbon(s) 
Perfluorocarbon 
concentration 
(%weight/volume) 
Surfactant(s)/ 
stabilizer(s) 
Typical 
storage 
conditions 
1. ‘First-Generation’ emulsions 
Fluosol Perfluorodecalin 14 Pluronic F-68 Frozen 
 Perfluorotripropylamine 6 EYP  
   Potassium oleate  
Perftoran Perfluorodecalin 14 Proxanol Frozen 
 Perfluoromethylcyclopiperidine 6   
     
Oxypherol Perfluorotributylamine 20 Pluronic F-68 Refrigeration 
     
2. ‘Second-Generation’ emulsions 
Oxygent Perflurobron 58 EYP Refrigeration 
 Perflurodecyl bromide 2   
     
Oxyfluor Perfluorodichlorooctane 76 Safflower oil Refrigeration 
   EYP  
TherOx Bis(perfluorobutyl)ethene  83 EYP Refrigeration 
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Fluorocarbon emulsions offer a simple, elegant and cost-effective vehicle for delivering 
oxygen to tissues. Further efforts will be focused in extending the range of therapeutic indications 
of such products. 
1.3 Perfluorocarbons 
 
The Fluorine (F) atom is characterized by a high electronegativity, relatively small size, 
very low polarizability, tightly bound with three non-bonding electron pairs, excellent overlap 
between F 2s and 2p orbitals with corresponding orbitals of other second period elements [14]. 
Fluorine has an electronegativity of 4.0 on the Pauling scale, which is the highest of all the 
elements. The incorporation of fluorine atoms into organic materials imparts dramatic changes in 
physical properties as well as chemical reactivities of the molecules. Actually, depending upon 
the site and level of fluorination, organofluorine compounds have solvent properties ranging from 
extreme non-polar perfluoroalkanes to the extraordinary polar solvent, hexafluoroisopropanol 
[14]. Physochemical properties of perfluoroalkane are shown in Table 1.2. 
 
Table 1.2 – Physicochemical properties of liquid perfluoroalkanes [15].  
Property Range Units 
Gas Solubility (310.15 K, 1 atm) 
Oxygen 33 – 66 mL/100 mL PFC 
Carbon Dioxide 140 – 210 mL/100 mL PFC 
Diffusion Coefficient (310.15 K, 1 atm) 
Oxygen 2 – 5.8 · 10-5 cm2/sec 
Carbon Dioxide 1.1 – 1.3 · 10-5 cm2/sec 
Vapor Pressure (310.15 K, 1 atm) 0.2 – 400 mm Hg 
Surface Tension (298.15 K, 1 atm) 13.6 – 18 dynes/cm 
Spreading Coefficient -0.2 to +4.5 dynes/cm 
Density (298.15 K, 1 atm) 1.58 – 2.02 g/mL 
Kinematic Viscosity (298.15 K, 1 atm) 0.8 – 8 cS 
Log P 6.1 – 9.7 – 
Lipid Solubility (310.15 K) 0.14 – 1.70 µgm PFC/mglipid/mmHg 
Data based on a survey of 18 liquid perfluoalkanes  
 
From the standpoint of the molecular structure, fluorocarbons have little similarity with the 
complex metal porphyrin-centered hemoglobin proteins. PFCs are synthetic, considerably smaller 
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and exceedingly simple molecules, with no structural requirements. Typical examples of 
fluorocarbons most investigated for oxygen delivery are shown in Figure 1.1 
 
 
a) 
 
b) 
 
c) 
 
d) 
 
e) 
Figure 1.1 – Most investigated fluorocarbons for oxygen delivery in humans: a) perfluorodecalin; b) 
perfluorotripropylamine; c) perfluoromethylcyclohexypiperidine; d) α,ω- dicholoroperfluorooctane; e) 
perfluorooctyl bromide (perfluorobron). 
 
Perfluorocarbons have numerous applications for biomedical purposes, such as using them 
pure as liquids for liquid ventilation or in the emulsified form for respiratory failure treatment 
[16]. They are also used as high-density intraoperative fluids for eye surgery [17], and as red cell 
blood substitutes, including all the situations of surgical anemia, some haemolytic anemia, 
ischemic disease, angioplasty, extracorporeal organ perfusion, cardioplegia [18], radiotherapy of 
tumours [19], and as an ultrasound contrast agent to detect myocardial perfusion abnormalities 
[20]. Furthermore, PFCs are used in oral use as a bowel marker during magnetic resonance 
imaging (MRI) [21]; in external application on patient’s body to improve magnetic homogeneity 
when fat saturation techniques are employed during magnetic resonance imaging (MRI) [22]; in 
ultrasound imaging [23] and a range of other applications of fluorocarbons in medicine are being 
explored [24]. 
In industry, there are a large number of documented applications of PFCs: as co-solvents in 
supercritical extraction improving the solubility of hydrophilic substances in supercritical reaction 
or extraction media [25]; as medium in two-phase reaction mixture, in separation and purification 
technique [26]; as refrigerants, aerosol propellants and foam blowing agents [27] and in cell 
culture aeration [28]. Besides, due to the exceptional solubility of carbon dioxide in 
perfluoroalkanes these compounds are being studied for industrial and environmental applications 
as the removal of carbon from gaseous effluents [29]. 
However, the perfluorocarbons present clear limitations such as high vapor pressures and 
poor solvating capacity for organic compounds, which might compromise their use as oxygen 
carriers. 
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1.4 Fluorinated Ionic Liquids 
 
1.4.1 Ionic Liquids 
 
The first ionic liquid (IL) was synthesized by Paul Walden in 1914, when he was testing 
new explosives for the substitution of nitroglycerin, the ethylammonium nitrate, with a melting 
point of 12 °C [30]. However, the first patent regarding an industrial application of ILs was filled 
in the preparation of cellulose solutions, being registered only in 1934 by Charles Graenacher 
[31]. A few more patents were registered during the 2nd World War [32, 33].  
However, in the last two decades, with the appearance of air and water stable ILs, the 
research and development of novel ILs and their possible applications increased significantly. The 
number of articles concerning ILs published between 1990 and 2011 are shown in Figure 1.2. 
 
 
Figure 1.2 – Number of papers published from 1990 to 2011. Values taken from ISI Web of Knowledge. 
 
Ionic liquids are salts, thus ionic compounds, that are liquid bellow a conventional 
temperature of 373 K [34]. This is due to their low symmetry [35, 36], ions with a high 
distribution of charge [37] low intermolecular interactions [38, 39] and dispersion caused by the 
large organic cation and organic or inorganic anion [40]. Among other unique thermophysical 
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properties ILs do not evaporate at ambient conditions [41]. The most common studied ILs are 
nitrogen-based and their general cation and anion structures are presented in Figure 1.3 and in 
Figure 1.4. 
 
 
 
 
pyrrolidinium imidazolium piperidinium 
  
pyridinium ammonium 
Figure 1.3 – Most common cation structures of nitrogen-based ILs. 
 
a) X ˉ 
 
 
f) OH ˉ 
 
b) NO3ˉ  
c) ClO4ˉ d) e)  g) 
    
l) ˉ MX 
  
m) [AlCl4]ˉ 
h) i) j) k)  [Al2Cl7]ˉ 
Figure 1.4 - Most common anion structures of ILs. a) halide (Clˉ,Fˉ,Brˉ,Iˉ); b) nitrate; c) chlorate; d) 
alkanoate; e) dicyanamide; f) hydroxide; g) trifluoromethanesulfonate; h) 
[bis(trifluoromethyl)sulfonyl]imide; i) hexafluorophosphate; j) tetrafluoroborate; k) alkyl sulfate; l) metal 
halide; m) chloroaluminates. 
 
Their ionic character provide them unique properties, such as negligible vapor pressure at 
room temperature, low flammability, high thermal and chemical stabilities, large liquid 
temperature range, high ionic conductivity, high solvation ability for organic, inorganic and 
organometallic compounds, improved selectivity and an easy recycling [41, 42]. ILs can be 
manipulated in the type and structure of the ions, according to their properties, such as 
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hydrophobicity, solution behaviour, thermophysical properties, biodegradation or toxicological 
[43, 44]. These properties made them improved alternatives to volatile organic compounds in the 
most diverse applications, such as in biphasic catalysis, in organic synthesis [45], in 
polymerization, in separation and extraction processes [46] and in the dissolution of biomaterials 
[47].  
Ionic liquids applications started to be devoted to electrolytes in batteries [48]. The area of 
electrochemical processes is still very significant, and important work is carried out toward 
integration of ILs into lithium-ion batteries, fuel cells or solar cells, as well as electrochemical 
syntheses and electrodeposition of metals [49]. Later, ILs were suggested as solvents and catalysts 
in reactions [36] and have been successfully tested for a wide variety of reactions: hydrogenations 
and hydroformylations, polymerizations, isomerizations, alkylations, acylations, Diels-Alder 
reactions, Heck and Suzuki coupling reactions, among others.  
Ionic liquids may be the basis of new technologies in liquid extraction [45] and gas 
separations [50]. Some other innovative solutions, related to the extraordinary ability of ILs as 
solvents, are currently studied, for instance the storage and delivery of hazardous gases absorbed 
in ILs [51] 
Due to the active work of research groups, as well as the interest of companies, often in 
mutual collaboration, a lot of applications currently in development will become real processes in 
the near future, thus increasing the portfolio of industrial applications based on ILs technology. 
The applications of the ILs are summarized in Figure 1.5. 
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Figure 1.5 – Application of ILs. 
 
1.4.2 Ionic Liquids with fluoroalkyl-functionalized groups 
 
Although the number of publications in ionic liquids has recently exponentially increased, 
there are unexploited subjects, namely the fluorinated ionic liquids (FILs) family, which are used 
in this work. The solvation in fully or partially fluorinated ionic liquids has particular interest in 
areas where PFCs are of relevant biomedical application, such as their use as in vivo gas carriers 
in liquid ventilation or artificial blood substitute formulation. This is viable due to the unique 
properties of fluorocarbons, namely high capacity for dissolving gases, low surface tension and 
outstanding chemical and biological inertness [3].  
The majority of articles published are only focused on the synthesis and characterization of 
FILs and their application as reaction media [52-60]. However, there are works where new 
fluorinated ionic liquids have been synthesized and studied for several applications, such as 
potential role in “green” chemical synthesis, catalysis, batteries and as electrolytes for fuel [53] as 
solar cells and as even telescope construction [61]; and as liquid crystals for optoelectronic 
applications [62]. The families and structure of some fluorinated ionic liquids from literature 
review are shown in Table 1.3. 
 
Applications	  
	  Chemical	  
industry	  
	  
Pharmaceutical	  
Batteries	  
Waste	  
recycling	  
Food	  and	  
bioproducts	  
	  Solar	  
thermal	  
Engineering	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Table 1.3 – Structure and family of fluorinated ionic liquids. 
Structure Family  Reference 
 
R = Me, Bu, Oc; Rfn = PFBu, PFHex, PFDe; 
A= I, BF4, PF6, OTs, OTf 
Phosphonium ionic liquids 
containing perfluoroalkyl 
substituent 
[63] 
  
A= I, OTf 
1,2,4-oxadiazolylpyridinium ionic 
liquids containing perfluoheptyl 
substituent 
[62] 
  
Rfn = PFBu, PFHex, PFOc, SF5PFBu 
Imidazolium ionic liquids 
containing perfluoroalkyl 
substituent with 
bis(trifluoromethylsulfonyl)imide 
anion 
[52, 54, 60, 
64] 
 
Rfn = PFHex, PFOc; 
A= I, BF4, PF6, NTf2, OTs, OTf 
Phosphonium ionic liquids 
containing tri-perfluoroalkyl and 
2,4,4-trimethylpentyl substituents  
[59, 65] 
 
A= Br, NTf2 
Phosphonium ionic liquids 
containing tri-perfluoroalkyl and 
dodecanethiol substituents 
[65] 
 
A= Br, PF6, NTf2 
Phosphonium ionic liquids 
containing bis-perfluoroalkyl, 
2,4,4-trimethylpentyl and 
hexanethiol substituents 
[58] 
 
R = Bu, Oc; Rfn = PFBu, PFOc, PFDe; A= I, NTf2, 
C3F7CO2H 
Ammonium ionic liquids 
containing perfluoroalkyl 
substituent 
[60] 
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Structure Family  Reference 
 
R = Me, Bu, Hep, De; Rfn = PFBu, PFHex 
Triazolium ionic liquids 
containing perfluoroalkyl 
substituent with 
bis(trifluoromethylsulfonyl)imide 
anion 
[60] 
 
A= NTf2, ClO4, BF4 
Triazolium ionic liquids 
containing perfluoroalkyl 
substituent  
[60] 
 
Rfn = PFHex, PFOc 
Bipyridinium ionic liquids 
containing perfluoroalkyl 
substituent with 
bis(trifluoromethylsulfonyl)imide 
anion 
[60] 
 
Rfn = EtSF5PFBu, EtPFHex 
Pyridinium ionic liquids 
containing perfluoroalkyl 
substituent with 
bis(trifluoromethylsulfonyl)imide 
anion 
[60] 
 
1-Methyl-4-
(3,3,4,4,5,5,6,6,7,7,8,8,8-
tridecafluorooctyl)1,2,4-
triazolium 
bis(trifluoromethylsulfonyl)imide 
[60] 
 
n = 2; A= NTf2, PF6 
Oxazolidinium ionic liquids 
containing perfluoroalkyl 
substituent 
[60] 
 
x = 6.5; y= 3.5; A= NTf2, I 
Imidazolium ionic liquids 
containing perfluoroalkyl PEG 
functionalized substituent 
[66] 
 
R = Et, Bu  
A= CHF2(CF2)3CH2SO4, (PFPh)NSO2(PFBu), 
CF3CHFO(CF2)2SO3, CF3CF2OCHFCF2SO3 
Imidazolium ionic liquids with 
anion containing perfluoroalkyl 
functionalized substituent 
[56, 59, 67] 
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Structure Family  Reference 
 
A= CHF2(CF2)3CH2SO4, (PFPh)NSO2(PFBu) 
1-Butyl-2,3-dimethylimidazolium 
with anion containing 
perfluoroalkyl functionalized 
substituent 
[56, 59, 67] 
 
R1 = Me, Et, Bu; R2 = Et, Bu, Oc; R3 = Et, Bu 
Ammonium ionic liquids with 
2,2,3,3,4,4,5,5-
octafluoropentanesulfate anion 
[59] 
 
Diethylpiperazinium 
2,2,3,3,4,4,5,5-
octafluoropentanesulfate 
[59] 
  
R = Et, Bu 
Pyridinium ionic liquids with 
2,2,3,3,4,4,5,5-
octafluoropentanesulfate anion 
[59] 
 
Tributylmethylphosphonium 
2,3,4,5,6-pentafluorophenyl-
nonafluorobutylsulfonamide 
[56] 
 
Diethylmethyl(2-
methoxyethyl)ammonium 
bis(perfluorobutanesulfonyl)imide 
[68] 
 
1-Butyl-1-methylpyrrolidinium 
(perfluorobutanesulfonyl) 
(trifluoromethylsulfonyl)imide  
[69] 
 
The high solubility of gases, especially carbon dioxide [52, 70] in FILs has already been 
demonstrated. A comparison between values for the CO2 solubility in [C8H4F13MIM][NTF2] FIL 
(mole fraction = 0.18 at 298.15 K and ≈ 5 bar) [70] and in perfluoro-n-octane (mole fraction = 
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0.104 at 293.15 K and 5.29 bar) [71] at similar conditions indicate that the new FILs have greater 
solubilisation capacities for this gas than the traditional PFCs. The transport properties of CO2, 
CH4, O2 and N2 in FILs using supported liquid membranes have been also tested [54]. The 
diffusivities and permeability presents the following general trends: O2 ≈ N2 > CH4 ≈ CO2 [54].  
Fluorinated surfactants are commonly used to promote high stability of various colloidal 
systems, including different types of emulsions or vesicles, and FILs have also shown a good 
behaviour as surfactant, remarkably facilitating the formation and stabilization of dispersions of 
perfluorocarbons in a conventional IL ([C6MIM][PF6]) [72]. FILs can display several behaviours 
common to surfactants: smaller surface tensions than those of conventional ILs; higher viscosity 
of the studied emulsions with the addition of FILs; and still, the most dramatic surfactant 
behaviour is their capacity to act as agents to promote and stabilize dispersion of PFCs in 
conventional ILs. In the absence of FILs, the emulsion aged in five minutes and when the 
experiment is repeated using FIL, the dispersion persist for week without visible change [72].  
All the above mentioned properties of the neat FILs are essential to apply the FILs-water 
and FIL+PFC-water emulsions as oxygen carriers in blood substitutes. Apart from a few examples 
[52, 55, 59, 60, 73], FILs thermophysical properties have never been evaluated, while the toxicity 
and biocompatibility of the new FILs have never been studied. Besides, solubility data, properties 
or phase behaviour or FILs+PFC have not been found in the literature. 
 
1.5 Objectives 
 
This work is a part of a broader project focused on the development of a new and improved 
generation of artificial blood substitutes containing fluorinated ionic liquids.  The overall 
objective of this work is to evaluate the thermophysical properties of some FILs and their liquid-
liquid phase equilibria with PFCs, in order to conclude about the feasibility of partially replacing 
PFCs in PFCs emulsions used as suitable oxygen carriers. The first part of this thesis includes the 
study of thermophysical properties of the FILs in order to compare with those of the PFC used as 
oxygen therapeutics. This thermophysical and thermodynamic characterization is centred on: 
 
• Melting and decomposition temperatures, because they determine the liquid range 
of these fluids and their range of application; 
• Viscosity, because the viscosity of oxygen carrier emulsions have to be within a 
very strict range so that they can be used in vivo;  
• Density, because the density of FILs should be similar to that of PFCs so that one 
single phase is easily obtained; 
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• Refractive index, which allows the free volume´s calculation that gives 
information about the capacity of fluorinated ionic liquids to solubilise respiratory gases; 
• Conductivity, that is directly related with ionicity and allowing us to compare 
FILs with other conventional ionic liquids and evaluate which compound is closest to ideal 
electrolyte. 
 
The second part of this thesis, addresses the phase behaviour of the FILs with PFC. The 
feasibility of using FIL for replacing, totally or in part, the PFC present in the emulsions will be 
evaluated through the liquid-liquid equilibria of binary mixtures of five fluorinated ionic liquids 
with perfluorodecalin and perfluorooctane. The experimental data will be correlated through non-
random two liquid model (NRTL). 
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2. Thermophysical Characterization of 
Fluorinated Ionic Liquids 
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2.1 Introduction 
 
The knowledge of thermophysical and transport properties of ILs, such as density, 
viscosity, ionic conductivity and refractive index, is crucial from an engineering point of view. 
This information is also vital for process scale up, since it decisively affects technological 
operations like mixing, pumping, and stirring, and plays a crucial role in other properties like 
diffusion [74]. A few examples of physical properties and thermal characterisation are reported 
for fluorinated ionic liquids [52, 54-56, 58-60, 63-69], and measurements of these properties have 
been performed for specific temperatures only. Therefore, there is a clear need for reliable 
systematic thermodynamic and thermophysical properties for these ionic liquids to point out their 
availability for use at the industrial processes level. 
The physicochemical properties of ILs in general and thus these FILs in particular can be 
fine-tuned through an adequate combination of the cation and the anion leading to the optimal 
physicochemical properties for each application. Nevertheless, this process would require wide 
collection of accurate physicochemical properties data for different families of FILs and the 
understanding of the relationships between each property and the ionic liquid intermolecular 
forces. This work provides a critical analyze of the thermodynamic and thermophysical properties 
of novel, non-volatile, recyclable fluorinated ionic liquids for the establishment of guidelines for 
selecting the most suitable FILs for development of new and improved generation of artificial 
blood substitute. This characterization involves analysis of decomposition temperature, melting 
point, density, dynamic viscosity, refractive index and ionic conductivity at atmospheric pressure 
in a large temperature interval. 
Melting and decomposition temperatures are important  properties of ionic liquids, 
especially for their application as alternative solvents, because they determine the liquid range of 
the fluids and thus their range of application. For example, the upper operating temperature of an 
ionic liquid is usually determined by the temperature at which it decomposes.  
Viscosity and density are the most relevant properties for any fluid phase; viscosity is a 
measure of the resistance of a fluid which is being deformed by either shear stress or tensile 
stress. The less viscous the fluid is, the greater its ease of movement (fluidity). All fluorinated 
ionic liquids have a viscosity higher than water [52, 55, 59, 60, 68] or PFCs [75, 76]. Therefore, 
the viscosity will increase with the addition of FILs to emulsions used as artificial blood 
substitutes. However, FILs with high viscosity should not be selected because might present 
problems in promoting the dispersion of fluorinated compound in water. On the other hand, PFCs 
used in artificial blood substitute have a density around 1.5 [77] and FILs with similar densities 
are good candidates to increase the fluorinated domains of the emulsion. Additional transport 
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properties, such as ionic conductivity and its relation with viscosity, known as ionicity, are also 
important for the characterization of pure fluorinated ionic liquids. 
Density, refractive index and related properties such as the molar free volumes can be 
related with the solubility of different species in mixtures containing ionic liquid, especially low 
molecular weight solutes that are gaseous at normal conditions [78]. Refractive index can also 
provide important insights of the electric polarizability of a molecule and can provide useful 
information when studying the forces between molecules or their behaviour in solution. The first 
refractive index data of this new class of ionic liquids are determined in this work. These data will 
allow the evaluation of these fluorinated ionic liquids to solubilise respiratory gases. 
 
2.2 Materials and Experimental Procedure 
 
2.2.1 Materials 
 
1-Methyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)imidazolium hexafluophosphate, 
>97% mass fraction purity; 1-butyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)imidazolium 
hexafluorophosphate, >97% mass fraction purity; tetrabutylammonium 
heptadecafluorooctanesulfonate, >97% mass fraction purity; tetrabutylammonium 
perfluorobutanesulfonate, >97% mass fraction purity; 1-ethyl-3-methylpyridinium 
perfluobutanesulfonate, >97% mass fraction purity; 1-mehtyl-3-octylimidazolium 
perfluorobutanesulfonate, >99%; 1-hexyl-3-methylimidazolium perfluorobutanesulfonate, >99% 
mass fraction purity and 1-butyl-1-methylpyrrolidinum perfluorobutanesulfonate, 98% mass 
fraction purity, were acquired at IoLitec and are shown in Table 2.1. All fluorinated ionic liquids 
were dried under vacuum (3·10-2 Torr) and vigorous stirred at 323.15K for at least 2 days, 
immediately prior to their use. This step is crucial in order to reduce volatile impurities, as well, 
as water, which can influence the ionic liquids properties. The water content, determined by Karl 
Fisher titration (Metrohm 831 Karl Fisher coulometer, shown in Figure 2.1), was less than 100 
ppm for all the studied ionic liquids. No further purification was carried out. The purity of the 
final products was checked by 1H-NMR. 
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Table 2.1 - Chemical structure and respective abbreviation of fluorinated ionic liquids. 
FIL Designation Chemical Structure 
1-Methyl-3-
(3,3,4,4,5,5,6,6,7,7,8,8,8-
tridecafluorooctyl)imidazolium 
hexafluophosphate 
[(EtPFHex)MeIm][PF6] 
 
1-Butyl-3-
(3,3,4,4,5,5,6,6,7,7,8,8,8-
tridecafluorooctyl)imidazolium 
hexafluorophosphate 
[(EtPFHex)BuIm][PF6] 
 
Tetrabutylammonium 
heptadecafluorooctanesulfonate 
[NBu4][(PFOc)SO3] 
 
Tetrabutylammonium 
perfluorobutanesulfonate 
[NBu4][(PFBu)SO3] 
 
1-Ethyl-3-methylpyridinium 
perfluobutanesulfonate 
[EtMepy][(PFBu)SO3] 
 
1-Mehtyl-3-octylimidazolium 
perfluorobutanesulfonate 
[OcMeIm][(PFBu)SO3] 
 
1-Hexyl-3-methylimidazolium 
perfluorobutanesulfonate 
[HexMeIm][(PFBu)SO3] 
 
1-Butyl-1-methylpyrrolidinum 
perfluorobutanesulfonate 
[BuMepyr][(PFBu)SO3] 
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Figure 2.1 - Metrohm 831 Karl Fisher coulometer used. 
 
2.2.2 Experimental Procedure 
 
Each fluorinated ionic liquid was taken from the respective schlenk flask with a syringe 
under a nitrogen flow to prevent humidity and was immediately placed in the apparatus. 
 
2.2.2.1 Thermal properties 
 
Thermogravimetric analyses (TGA) were carried out with a TA instrument model TGA 
Q50, shown in Figure 2.2, and the thermal stabilities and decomposition temperatures of the 
fluorinated ionic liquids were measured. Nitrogen was used for the TGA measurements at a flow 
rate of 60 mL.min-1. Samples were placed inside aluminium pans and heated to 873 K at a rate of 
1 K.min-1 until complete thermal degradation was achieved. Universal Analysis, version 4.4 
software, was used to determined the onset (Tonset), the starting (Tstart) and the decomposition (Tdec) 
temperatures corresponding to the temperature at which the baseline slope changed during 
heating, the weight loss was less than 1 % and the weight loss was 50 %, respectively. A 
Differential Scanning Calorimeter TA Instrument model DSC Q200 (DSC), shown in Figure 2.3, 
was used to measure the thermal properties of the fluorinated ionic liquids. The sample was 
continuously purged with 50 mL.min-1 dinitrogen. About 5 to 10 mg of fluorinated IL was 
crimped in an aluminum standard sample pan. Indium (melting point T = 429.76 K) was used as 
standard compound for the calibration of the DSC. 
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Figure 2.2 – Thermogravimetric analyses model 
TGA Q50 (TGA). 
 
Figure 2.3 – Differential scanning calorimeter 
model DSC Q200 (DSC). 
 
2.2.2.2 Viscosity and density measurements 
 
Measurements of viscosity and density were performed in the temperature range between 
283.15 and 353.15 K at atmospheric pressure using an automated SVM 3000 Anton Paar 
rotational Stabinger viscometer-densimeter (Figure 2.4). The SVM 3000 uses Peltier elements for 
fast and 49epresent thermostability. The temperature uncertainty is ± 0.02 K. The precision of the 
dynamic viscosity measurements is ± 0.5% and the absolute uncertainty of the density is ± 0.0005 
g.cm-3. For each fluorinated ionic liquid, triplicates were measured and the reported result is the 
average value with a maximum relative standard deviation (RSD) of 0.51%. 
 
 
Figure 2.4 – SVM 3000 Anton Paar rotational Stabinger viscometer-densimeter. 
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2.2.2.3 Refractive index measurements 
 
The refractive 50epre of the 50epr ionic liquids were determined using the automatic 
refractometer ABBEMAT 500 Anton Paar (Figure 2.5) with a resolution of ± 10-6 and the 
uncertainty in the experimental measurements of ± 4·10-5. The apparatus was calibrated by 
measuring the refractive 50epre of Millipore quality water and tetrachloroethylene (provided by 
the supplier) before each 50epres of measurements. 
 
 
Figure 2.5 – Refractometer ABBEMAT 500 Anton Paar. 
 
2.2.2.4 Ionic conductivity measurements 
 
A CDM210 Radiometer Analytical conductimeter (Figure 2.6) was used to measure the 
ionic conductivities in a jacketed glass cell containing a magnetic stirrer. A water bath controlled 
to ± 0.01 K was used to thermostatize the cell. Cell temperature was measured by means of a 
platinum resistance thermometer coupled to a Keithly 199 System DMM/Scanner. The 
thermometer was calibrated against high accuracy 50eprese thermometers (0.01 K). For the 
electrical conductivity measurements, 1.5 mL of the sample was added to the thermostatic cell 
and vigorously stirred. The cell was closed with screw caps to ensure a secure seal and flushed 
with dry nitrogen to prevent humidity. Each measurement was performed as quickly as possible to 
minimize undesired effects, such as self-heating of the samples or ionization in the electrodes [79, 
80] that might modify the measured conductivity values. This conductimeter uses an alter current 
of 12 V and a frequency of 2.93 kHz (4.00 mS range) in the range of conductivities measured. 
The use of high frequency alter current (greater than 600 Hz) and the fact that the electrodes are 
platinized avoids polarization phenomena at the 50epresen of the cell electrodes [80, 81]. The 
conductimeter was previously calibrated at each temperature with certified 0.01 D and 0.1 D Kcl 
standard solutions supplied by Radiometer Analytical. This technique was validated using the 
pure ionic liquids 1-ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide and 1-hexyl-3-
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methylimidazolium bis(trifluoromethylsulfonyl)imide. The obtained results were compared with 
the published data using the impedance method [82, 83] showing maximum relative deviations of 
2%. Every conductivity value was determined at least three times and the uncertainty of the 
measurements is estimated to be 1% in absolute value. 
 
 
Figure 2.6 – CDM210 Radiometer analytical conductimeter. 
 
2.3 Results and Discussion 
 
2.3.1 Thermal properties 
 
Melting and decomposition temperatures, are one of the most remarkable properties for ionic 
liquids, especially for their application as alternative 51epresent, because they determine the 
liquid range of the fluids and their range of application, which make them the most studied 
properties. The 51epres properties (51epres stabilities, decomposition temperatures, melting 
points and glass transition temperatures see Appendix A) of the fluorinated ionic liquids studied 
in this work are summarized in Table 2.2. The melting points and decomposition temperatures for 
these fluorinated ionic liquids are illustrated in Figure 2.7. 
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Table 2.2 – Thermal properties of fluorinated ionic liquids: start temperature, Tstart, onset temperature, 
Tonset, decomposition temperature, Tdec, melting temperature, Tm, and glass transition temperature, Tg. 
 Tstarta / K Tonseta / K Tdeca / K Tm / K  Tg / K 
[(EtPFHex)MeIm][PF6] 429.93 535.20 544.39 338.94 236.18 
[(EtPFHex)BuIm][PF6] 420.52 519.75 557.73 362.57 − 
[Nbu4][(PFOc)SO3] 373.67 385.08 402.61 255.14 225.72 
[Nbu4][(PFBu)SO3] 545.07 587.04 619.21 327.13 234.45 
[HexMeIm][(PFBu)SO3] 565.56 627.00 666.18 296.78 264.07 
[OcMeIm][(PFBu)SO3] 581.98 621.41 655.78 308.13 − 
[EtMepy][(PFBu)SO3] 574.13 629.10 651.89 277.85 − 
[BuMepyr][(PFBu)SO3] 588.99 632.25 650.62 632.08 − 
a Note that these values are from scanning TGA, and do not 52epresente isothermal stabilities. 
 
 
Figure 2.7 – Melting points and decomposition temperatures of the fluorinated ionic liquids studied in this 
work. 
 
In order to explore the application of fluorinated ionic liquids for artificial gas carriers and 
blood substitutes the most relevant temperature is 310.15 K since it is accepted as the average 
temperature of human body. From Figure 2.7 [EtMepy][(PFBu)SO3]  is the ionic liquid that has 
the highest thermal stability and the lowest melting point, constituting thus the most promising 
candidate in terms of thermal properties. The results also indicate that the melting points of FILs 
based on perfluorobutanesulfonate anion ([BuMepyr][(PFBu)SO3], [NBu4][(PFBu)SO3], 
[HexMeIm][(PFBu)SO3], [OcMeIm][(PFBu)SO3] and [EtMepy][(PFBu)SO3]) decrease in the 
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following order: pyrrolidiums > ammonium > imidazoliums > pyridiniums. In ammonium-based 
ionic liquids, the increment of fluorinated chain decreases the decomposition and the melting 
temperatures ([NBu4][(PFOc)SO3] <.[NBu4][(PFBu)SO3]). 
 
2.3.2 Thermophysical and thermodynamic properties 
 
The experimental density, dynamic viscosity, refractive index and ionic conductivities of 
fluorinated ionic liquids as a function of temperature are listed in Table 2.3. 
 
Table 2.3 – Density, ρ, dynamic viscosity, η, refractive index, nD, and ionic conductivity, k, of the pure 
fluorinated ionic liquids as a function of temperature. 
T/K ρ/g.cm-3 η/mPa.s nD k/mS.cm-1 
[NBu4][(PFOc)SO3] 
283.15 − − 1.40102 1.28 · 10-3 
288.13 − − 1.39946 2.44 · 10-3 
293.15 1.3215 12159 1.39788 4.41 · 10-3 
298.15 1.3173 6690 1.39625 7.39 · 10-3 
303.15 1.3129 3879 1.39478 1.22 · 10-2 
308.15 1.3083 2340 1.39321 1.89 · 10-2 
313.15 1.3034 1464 1.39165 2.86 · 10-2 
318.15 1.2984 947.2 1.39006 4.19 · 10-2 
323.15 1.2934 631.9 1.38849 5.95 · 10-2 
328.15 1.2882 433.5 1.38692 − 
333.15 1.2833 305.1 1.38535 − 
338.15 1.2783 219.9 1.38373 − 
343.15 1.2735 161.9 1.38205 − 
348.15 1.2686 121.6 − − 
353.15 1.2638 92.94 − − 
[NBu4][(PFBu)SO3] 
293.15 1.2371 28508 1.41696 − 
298.15 1.2335 15319 1.41547 − 
303.15 1.2301 8622 1.41400 − 
308.15 1.2266 5059 1.41249 − 
313.15 1.2230 3081 1.41101 − 
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T/K ρ/g.cm-3 η/mPa.s nD k/mS.cm-1 
318.15 1.2192 1946 1.40954 − 
323.15 1.2152 1265 1.40814 − 
328.15 1.2111 846.5 1.40669 − 
333.15 1.2069 581.3 1.40522 − 
338.15 1.2028 409.1 1.40364 − 
343.15 1.1987 294.4 1.40231 − 
348.15 1.1944 216.2 − − 
353.15 1.1899 161.8 − − 
[HexMeIm][(PFBu)SO3] 
293.15 1.3967 570.0 1.40987 0.218 
298.15 1.3918 401.7 1.40847 0.299 
303.15 1.3871 290.2 1.40704 0.401 
308.15 1.3824 214.4 1.40562 0.527 
313.15 1.3778 161.6 1.40421 0.678 
318.15 1.3732 124.1 1.40281 0.857 
323.15 1.3686 96.98 1.40130 1.07 
328.15 1.3639 76.95 1.40005 − 
333.15 1.3593 61.92 1.39867 − 
338.15 1.3546 50.49 1.39731 − 
343.15 1.3499 41.66 1.39595 − 
348.15 1.3450 34.76 − − 
353.15 1.3401 29.31 − − 
[OcMeIm][(PFBu)SO3] 
298.15 1.3381 374.6 1.412790 − 
303.15 1.3332 344.9 1.41134 − 
308.15 1.3287 252.9 1.40990 0.355 
313.15 1.3242 189.2 1.40848 0.461 
318.15 1.3197 144.3 1.40710 0.588 
323.15 1.3153 111.9 1.40568 0.732 
328.15 1.3109 88.21 1.40430 − 
333.15 1.3065 70.53 1.40289 − 
338.15 1.3020 57.15 1.40152 − 
343.15 1.2976 46.88 1.40008 − 
348.15 1.2931 38.89 − − 
353.15 1.2885 32.61 − − 
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T/K ρ/g.cm-3 η/mPa.s nD k/mS.cm-1 
[EtMepy][(PFBu)SO3] 
283.15 1.5306 578.9 1.42439 0.405 
288.13 1.5252 394.8 1.42290 0.565 
293.15 1.5199 278.2 1.42142 0.765 
298.15 1.5148 201.8 1.41997 1.01 
303.15 1.5098 150.3 1.41850 1.30 
308.15 1.5048 114.4 1.41703 1.64 
313.15 1.4998 88.98 1.41554 2.03 
318.15 1.4949 70.46 1.41405 2.48 
323.15 1.4899 56.72 1.4899 2.97 
328.15 1.4850 46.34 1.4850 − 
333.15 1.4802 38.39 1.4802 − 
338.15 1.4753 32.18 1.4753 − 
343.15 1.4704 27.26 1.4704 − 
348.15 1.4655 23.33 1.4655 − 
353.15 1.4607 20.15 1.4607 − 
 
The densities, fluidities (1 / dynamic viscosity) and ionic conductivities of the fluorinated 
ionic liquids are shown in Figure 2.8, Figure 2.9 and Figure 2.10, respectively, as function of the 
temperature. 
 
 
Figure 2.8 – Density and fitted curves as a function of temperature for the fluorinated ionic liquids. 
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Figure 2.9 – Fluidity (1/viscosity) and fitted curves as a function of temperature for the fluorinated ionic 
liquids. 
 
 
Figure 2.10 – Ionic conductivity and fitted curves as a function of temperature for the fluorinated ionic 
liquids. 
 
The temperature dependence of the density and the refractive index was studied by applying 
the following expression: 
ln ρ = A0  +  A1T (2.1) 
nD = A0  +  A1T (2.2) 
where T is the absolute temperature and 𝐴!, and 𝐴! are adjustable parameters. The correlation 
parameters are given in Table 2.4 together with the standard deviations (S.D.). These deviations 
were calculated by applying the following expression: 
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S.D. = zexp − zadjust 2nDAT!
nDAT
1
2
 
(2.3) 
where property values and the number of experimental and adjustable data are represented by z 
and nDAT, respectively. 
 
Arrenius fitting for fluidity, ϕ, and of the ionic conductivity, 𝑘, was well carried out using 
Vogel-Fulcher-Tammann (VFT) equation: 
   P =   P!exp −𝐵𝑇 − 𝑇!  (2.4) 
 
where P designates the thermophysical property (fluidity, ϕ, or ionic conductivity, 𝑘) and P! 
corresponds to ϕ! or 𝑘!. B and T0 are constants. The fitting parameters of the fluidity and ionic 
conductivity are also summarized in Table 2.4. This equation is used to show temperature 
dependence of ionic conductivity and fluidity. 
 
Density and fluidity (inverse of dynamic viscosity) are relevant characteristics, when it 
comes to blood substitutes, since they are crucial for O2 and CO2 transport and delivery [84]. Both 
these properties show similar behaviour: the denser and less viscous FIL is the 
[EtMepy][(PFBu)SO3], followed by imidazolium based on [(PFBu)SO3] ˉ anion. 
 
Table 2.4 - Fitting parameters for the density (equation 2.1), refractive index (equation 2.2), fluidity 
(equation 2.4) and ionic conductivity (equation 2.4) as a function of temperature for the studied fluorinated 
ionic liquids. Standard deviations (S.D.) (equation 2.3) are also shown. 
[NBu4][(PFOc)SO3] ln 𝜌 /g.cm-3 A0 = 0.5008 A1 = - 7.547 · 10-4 − S.D. = 3.4 . 10-4  
nD A0 = 1.4902 A1 = - 3.150 · 10-4 − S.D. = 5.0 . 10-5  
ϕ/ mPa-1.s-1 φ0 = 3.75
 B = 707.29 T0 = 232.5 S.D. = 7.7 . 10-5 
k/ mS.cm-1 k0 = 1334.6
 B = 1349.7 T0 = 186.4 S.D. = 4.5 . 10-4 
[NBu4][(PFBu)SO3] ln 𝜌 /g.cm-3 A0 = 0.4037 A1 = - 6.482 · 10-4 − S.D. = 5.5 . 10-4  
nD A0 = 1.5029 A1 = - 2.934 · 10-4 − S.D. = 4.3 . 10-5  
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ϕ/ mPa-1.s-1 φ0 = 2.14
 B = 707.34 T0 = 232.8 S.D. = 9.0 . 10-5 
[HexMeIm][(PFBu)SO3] ln 𝜌 /g.cm-3 A0 = 0.5346 A1 = -6.840 · 10-4 − S.D. = 1.5 . 10-4 
nD A0 = 1.4920 A1 = -2.801 · 10
-4 − S.D. = 6.1 . 10-5 
ϕ/ mPa-1.s-1 φ0 = 3.75 B = 705.46  T0 = 203.34 S.D. = 2.0 . 10-4 
k/ mS.cm-1 k0 = 1376.8 B = 1186.9 T0 = 157.4 S.D. = 1.4 . 10-3 
[OcMeIm][(PFBu)SO3] ln 𝜌 /g.cm-3 A0 = 0.5006 A1 = -6.802 · 10-4 − S.D. = 3.4 . 10-4 
nD	   A0 = 1.4967 A1 = -7.008 · 10-4 − S.D. = 2.7 . 10-5 
ϕ/ mPa-1.s-1 φ0 = 3.56 B = 706.04 T0 = 205.01 S.D. = 3.2 . 10-4 
k/ mS.cm-1 k0 = 1381.1 B = 1295.0 T0 = 151.4 S.D. = 1.8 . 10-3 
[EtMepy][(PFBu)SO3] ln 𝜌 /g.cm-3 A0 = 0.6136 A1 = - 6.648 · 10-4 − S.D. = 1.1 . 10-4  
nD	   A0 = 1.5094 A1 = - 3. 001 · 10-4  − S.D. = 7.4 . 10-5  
ϕ/ mPa-1.s-1 φ0 = 4.12 B = 704.89 T0 = 193.8 S.D. = 1.3 . 10-4 
k/ mS.cm-1 k0 = 1430.0 B = 1028.1 T0 = 156.5 S.D. = 1.4 . 10-2 
 
2.3.3 Free Volume 
 
The refractive index can be used as a measure of the electric polarizability of a molecule 
and can provide useful information when studying the forces between molecules or their 
behaviour in solution [78]. Polarizability is the measure of the change in a molecule's electron 
distribution in response to an applied electric field, which can also be induced by electric 
interactions with solvents or ionic solvents. Polarizabilities determine the dynamical response of a 
bound system to external fields, and provide insight into a molecule's internal structure [85]. The 
Lorenz-Lorentz equation relates the electronic polarizability, 𝛼!, with the refractive index, 𝑛!, 
and can also be expressed in terms of the molar refraction, or molar polarizability [86], Rm, using 
the expression: 
 𝑅! = 𝑁!𝛼!3𝜀! = 𝑛!! − 1𝑛!! + 2 𝑉! (2.5) 
where the 𝑁! is the Avogadro’s constant and 𝑉! the molar volume. 
The relation between the polarizability and the refractive index shown above can provide 
important information about the behaviour of a liquid as a solvent medium and constitutes a 
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measure of the importance of the dispersion forces to the cohesion of the liquid. Therefore, 
solvents with a large index of refraction, and consequently large polarizability, should be capable 
of enjoying particularly strong dispersion forces [87], being also good solvents for species 
possessing high polarizabilities. Molar refractions can be considered as a measure of the hard-core 
molecular volumes because the electronic polarizability can be related to a spherical molecular 
radius [78], 𝑎, as follows: 
 𝛼! = 4πε!𝑎! (2.6) 
and the equation 2.5 can be expressed in the following form: 
 
𝑛!! − 1 = 3 𝑉!𝑅! − 1 !! = 3 𝑅!𝑓!  (2.7) 
 
where 𝑓! is the free volume defined as: 
 𝑓! = (𝑉! − 𝑅!) (2.8) 
 
which means that (𝑛!! − 1) is directly proportional to the occupied part of the molar volume, Rm 
being then considered as the hard-core molecular volume [88, 89].  
The molar free volumes can be related to the solubility of low molecular weight solutes that 
are gaseous at normal conditions [78]. The values for the calculated molar refractions (from 
equation 2.5) and free volumes (from equation 2.8), from Lorentz-Lorenz equation, of all the 
studied fluorinated ionic liquids were calculated and are listed in Table 2.5 together with the 
values for molar volume.  
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Table 2.5 – Values of calculated molar volume, Vm, molar refraction, Rm, and free volume, fm, as a function 
of temperature for the studied fluorinated ionic liquids. 
T/K 𝑽𝐦/cm3·mol-1 𝑹𝐦/cm3·mol-1 𝒇𝐦/cm3·mol-1 
[NBu4][(PFOc)SO3] 
293.15 561.12 135.39 425.73 
298.15 562.93 135.33 427.60 
303.15 564.82 135.34 429.47 
308.15 566.80 135.34 431.46 
313.15 568.93 135.37 433.56 
318.15 571.12 135.40 435.72 
323.15 573.33 135.44 437.89 
328.15 575.62 135.49 440.13 
333.15 577.85 135.52 442.32 
338.15 580.08 135.54 444.54 
343.15 582.29 135.53 446.77 
[NBu4][(PFBu)SO3] 
293.15 437.73 110.07 327.66 
298.15 439.01 110.04 328.97 
303.15 440.22 110.01 330.22 
308.15 441.48 109.97 331.51 
313.15 442.78 109.94 332.84 
318.15 444.16 109.94 334.22 
323.15 445.62 109.97 335.66 
328.15 447.13 109.99 337.14 
333.15 448.69 110.03 338.66 
338.15 450.22 110.02 340.20 
343.15 451.76 110.08 341.68 
[HexMeIm][(PFBu)SO3] 
293.15 333.87 82.70 251.17 
298.15 335.06 82.74 252.32 
303.15 336.19 82.77 253.43 
308.15 337.33 82.79 254.54 
313.15 338.46 82.81 255.65 
318.15 339.59 82.84 256.76 
323.15 340.74 82.84 257.90 
328.15 341.89 82.89 259.00 
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T/K 𝑽𝐦/cm3·mol-1 𝑹𝐦/cm3·mol-1 𝒇𝐦/cm3·mol-1 
333.15 343.06 82.92 260.14 
338.15 344.25 82.96 261.29 
343.15 345.46 83.00 262.46 
[OcMeIm][(PFBu)SO3] 
298.15 369.49 92.09 277.40 
303.15 370.85 92.15 278.70 
308.15 372.10 92.17 279.93 
313.15 373.37 92.20 281.17 
318.15 374.63 92.24 282.39 
323.15 375.90 92.27 283.63 
328.15 377.17 92.30 284.87 
333.15 378.44 92.33 286.11 
338.15 379.73 92.36 287.36 
343.15 381.03 92.39 288.65 
[EtMepy][(PFBu)SO3] 
283.15 275.21 70.28 204.92 
288.15 276.19 70.32 205.88 
293.15 277.14 70.34 206.80 
298.15 278.08 70.37 207.71 
303.15 279.01 70.39 208.62 
308.15 279.93 70.40 209.53 
313.15 280.86 70.41 210.45 
318.15 281.78 70.42 211.36 
323.15 282.73 70.43 212.30 
328.15 283.66 70.40 213.25 
333.15 284.59 70.41 214.18 
338.15 285.52 70.42 215.10 
343.15 286.48 70.45 216.03 
 
The molar free volumes of fluorinated ionic liquids are plotted in Figure 2.11. The analysis 
of molar free volume indicates that the increment of alkyl and fluorinated chain increases the 
molar free volume, which might be beneficial for the use of these fluids as gases carriers. It has 
been shown that the oxygen and the carbon dioxide solubility in fluorinated compounds is largely 
governed by entropic contributions, meaning that the creation of free cavities which can better 
accommodate the gas molecules might enhance the gas solubility of these.  
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Figure 2.11 – Molar free volume as a function of temperature for the fluorinated ionic liquids.  
 
A combined analysis of the results obtained so far from Figure 2.8 to Figure 2.11, shows 
that [EtMepy][(PFBu)SO3] can be a good election because can increase viscosity of PFC-based 
emulsions and has a similar density to PFCs (PFCs used in artificial blood substitute have a 
density around 1.5 [90]) favouring the easy preparation of solutions. However, this fluorinated 
ionic liquid presents the lowest value of molar free volume (calculated from density and refractive 
index), which can be attributed to the small perfluorinated chain present in this anion combined 
with short alkyl chains in the cation. The highest free volume is obtained for the 
[NBu4][(PFOc)SO3] FIL which has a octylperfluorooctyl chain in the anion combined with 
tetrabutylammonium cation. 
 
2.3.4 Walden Plot 
 
The Walden plot is a convenient and versatile tool to measure the ionicity of ionic liquids [91, 
92] since it establishes a relationship between the molar conductivity and the viscosity of a fluid. 
A way to determine the efficiency of an ionic liquid as an electrolyte, solvent, or reaction medium 
[93], has been proposed by Walden rule [94]. The Walden rule gives information on the 
relationship between ion mobility and viscosity. In the case of an ideal ionic liquid conductor, 
conductivity is only influenced by the viscosity [95] in the form: 
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Molar conductivity = C𝜂  (2.9) 
where the molar conductivity is expressed in S cm2 mol-1 and the viscosity (𝜂) is expressed in 
Poise, and C is a constant. “The fractional” Walden model added an exponent α [96]. 
 
Molar conductivity ∝    1𝜂 ! (2.10) 
 
For ionic liquids, it has been shown that the molar conductivity can be calculated by [95]: 
 
Molar conductivity = 𝑘𝜌Mw (2.11) 
 
with the 𝑘 conductivity in S cm-1, the 𝜌 the density in g cm-3 and Mw the molecular weight in g 
mol-1. The eq. (2.11) can be also expressed by: 
 log  (Molar conductivity) = 𝛼  log 1𝜂 + log  C (2.12) 
 
The Walden-plot is usually represented by the log Molar conductivity  as a function of 
log 1 𝜂  [96] and is a good and versatile tool to measure ionicity of inorganic salts solutions and 
ionic solvents. The straight line of Figure 2.12 fixes the position of the “ideal” electrolyte, where 
the system is known to be fully dissociated and to have ions of equal mobility. Usually, the 
behaviour of diluted aqueous potassium chloride solutions are taken as the behaviour of an ideal 
electrolyte [97]. For the unit chosen, the ideal line runs from corner to corner of a square diagram 
[98]. Figure 2.12 shows the classification proposed by Angell and co-workers [91, 98] for “good” 
and “poor” ionic liquids. 
Experimental information on ionicity of fluorinated ionic liquids is extremely scarce in 
literature review and experimental data are available for only two FILs [91, 92]. The data 
obtained for the four fluorinated ionic liquids studied in this work are represented in Figure 2.12 
together with the classification proposed by Angell and co-workers [92, 99]. For each fluorinated 
ionic liquid, the Walden plot has a linear behaviour with the temperature. The behaviour of 
[EtMepy][(PFBu)SO3] is the closest to ideal electrolyte (straight black line) and the ionicity 
decreases in the following order: [EtMepy][(PFBu)SO3] > [HexMeIm][(PFBu)SO3] > 
[OcMeIm][(PFBu)SO3] > [NBu4][(PFOc)SO3]. 
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Figure 2.12 – Walden plot for the fluorinated ionic liquids. 
 
2.4 Conclusions 
 
The goal of this chapter was to report the measurent of the thermodynamic and 
thermophysical properties of 8 FILs in order to understand its behaviour as pure fluid so that they 
can be used in oxygen therapeutics based on PFCs-emulsions. 
The viscosity of PFC-based emulsions should increase when a good surfactant is added 
with the aim to enhance the stability of emulsions. All the fluorinated ionic liquids have higher 
viscosity than the PFCs and can increase the stability of actual oxygen therapeutics. However, the 
FILs with higher viscosity should not be selected because they can present problems to promote 
dispersion of fluorinated compounds in the water. 
By the behaviour of thermodynamic and thermophysical properties, it may be conclude that 
[EtMepy][(PFBu)SO3] is a good election because it has the lowest viscosity and a density similar 
to that of PFC-based emulsions and thus would not present any problems in the preparation or 
stability of the emulsion. However, [EtMepy][(PFBu)SO3] presents the lowest value of molar free 
volume, which may hinder the solubility of respiratory gases. 
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3. Liquid-Liquid Equilibria of 
Perfluorocompounds with Fluorinated 
Ionic Liquids 
Development of New Oxygen Therapeutics using Fluorinated Ionic Liquids 
  66 
Liquid-Liquid Equilibria of Perfluorocompounds with Fluorinated Ionic Liquids 
 67 
3.1 Introduction 
 
In system at equilibrium [100], the number of variables is called the number of degrees of 
freedom (f) and is related to the number of components (c) and number of phases (n) as follows, 
at constant pressure: 
 
f=c  +  1 −   n (3.1) 
 
This is a key rule in the study of phase equilibria, and has influences in the way in which 
the liquid-liquid equilibrium (LLE) data are represented [101]. The word “equilibrium” denotes 
the absence of change and the absence of any tendency towards change on a macroscopic scale. 
The phase diagrams are a useful graphical representation of phase equilibria, guided by 
application of the phase rule, where data are easy to apply and read. For a binary liquid system, 
the most common phase diagram is the so-called temperature-composition diagram, at constant 
pressure, whereas temperature is represented in the y-axis and composition in the x-axis. 
Therefore, the number of degree of freedom available will be f=2 if there is homogeneity in the 
system, but only f=1 if the system presents two immiscible phases. 
From the first law of thermodynamic, (which says although energy assumes many forms, 
the total quantity of energy is constant, and when energy disappears in one form it appears 
simultaneously in other forms), and the second law, (which says that it is impossible by a cyclic 
process to convert the heat absorbed by a system completely into work done by the system and 
that no process is possible which consist solely in the transfer of heat from one temperature level 
to a higher one), can be demonstrable [102] that the equilibrium state of a closed system at a 
constant temperature and pressure is the state for which the total Gibbs energy (G) is at a 
minimum with respect to all possible changes at the given temperature and pressure, and can be 
expressed as: 
 𝑑𝐺 !,!  =  0 (3.2) 
 
which is valid regardless of the number of phases and components in the system. 
 
The experimental methods for determining phase equilibria can be classified in two main 
categories: the synthetic and the analytical. The synthetic method involves the preparation, 
usually by mass, of a mixture of known composition, followed by a measurement of the 
temperature at which the phase separation is formed or disappears. Traditionally visual 
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observation of the clear and/or cloud points of the mixtures is used [103]. The advantages of the 
synthetic method are essentially applicability and the simplicity while the two major 
disadvantages is that both components and their mixtures must be stable at the microscopic 
timescale up to the maximum temperature of interest [103]. The analytical method requires that 
the different phases are in equilibrium, allowing for the separation. Then, samples of both phases 
are analysed by some appropriate method (measuring the refractive index, titration, 
spectrophotometry, chromatography, etc.). This method is usually the method of choice, because 
of its accuracy, speed, simplicity and lack of requirement for specialized apparatus [44]. 
However, this method can be more time consuming in systems that require large equilibration 
times and large phase separation periods. In order to obtain accurate measurements, a complete 
separation of the phases must be achieved before sampling. 
 
In this work, the liquid-liquid phase equilibria behaviour of perflurocarbons and fluorinated 
ionic liquids will be measured. The aim of this study is to evaluate the possible replacement 
totally or partially of the perfluorocarbons used in artificial blood substitutes by fluorine ionic 
liquids, in order to provide a more stable product. Two perfluorocarbons where chosen, 
perfluorodecalin and perfluorooctane, since these compounds, or compounds derived from them, 
have been the most studied for this application. 
The experimentally obtained liquid-liquid equilibrium data are correlated using Non Random 
Two-Liquid Model (NRTL) equation, which is a semi-empirical model [104] that takes account of 
the non-random nature of liquid mixtures by using the concept of a local composition. This 
model, although simplistic, can attest the thermodynamic consistency of the measured data. 
 
3.2 Materials and Experimental Procedure 
 
3.2.1 Materials 
 
1-Methyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)imidazolium  hexafluophosphate, 
>97% mass fraction purity; 1-butyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)imidazolium 
hexafluorophosphate, >97% mass fraction purity; tetrabutylammonium 
heptadecafluorooctanesulfonate, >97% mass fraction purity; tetrabutylammonium 
perfluorobutanesulfonate, >97% mass fraction purity; 1-ethyl-3-methylpyridinium 
perfluobutanesulfonate, >97% mass fraction purity; 1-mehtyl-3-octylimidazolium 
perfluorobutanesulfonate, >99%; 1-hexyl-3-methylimidazolium perfluorobutanesulfonate, >99% 
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mass fraction purity and 1-butyl-1-methylpyrrolidinum perfluorobutanesulfonate, 98% mass 
fraction purity, were acquired at IoLitec, and are shown in Table 2.1. The ionic liquid 1-butyl-3-
methylimidazolium bis(trifluoromethylsulfonyl) imide, 99% mass fraction purity from IoLitec, 
were used for the method validation. Ionic liquids were dried under constant agitation in vacuum 
(3·10-2 Torr) and at 323.15 K, for a minimum of 48 h immediately prior to their use. 
Perfluorodecalin, 96% mass fraction purity and perfluorooctane, >99% mass fraction purity were 
supplied by Apollo Scientific and are shown in Table 3.1.  
 
Table 3.1 - Chemical structure and respective abbreviation of perfluorocarbon. 
PFC Designation Chemical Structure 
 
Perfluorodecalin 
 
 
Perfluorooctane 
 
 
3.2.2 Procedure 
 
3.2.2.1 Liquid-Liquid Equilibria 
 
Liquid-liquid equilibria was studied for the 9 binary mixtures perfluorocarbons + 
fluorinated ionic liquids in the temperature range from T = 293.15 to 343.15 K and at atmospheric 
pressure. 
Preliminary studies indicated in the studied systems, the solubility of the selected FILs in 
the two chosen PFC are very small, almost close to zero. On the other hand, the solubilities of the 
PFCs in the FILs were found to be larger, around 0.8 of FIL in molar fraction. These facts 
dictated the choices of the different experimental methodologies (synthetic and the analytical) 
adopted for determination of both PFC-rich and FIL-rich sides of the phase diagram.  
The solubility of each perfluorocarbon in FIL-rich phase was determined by the analytical 
method, using refratometry. The measurements were started with an addition of 3 ml of an 
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immiscible binary mixture (Figure 3.1) of known composition inside of a glass cell. The 
temperature was set and the mixture was vigorously stirred for 1 h, which was found to be the 
adequate period of time to reach the equilibrium. Then, a needle was inserted through the septum 
of the cell in FIL-rich phase, in order to not disturb the equilibrium (special capped needles were 
used in order to avoid contamination from one phase with the other) and left to settle for 48 h. In 
this period, the complete separation of the two phases was achieved. Samples were taken by a 
heated syringe from the upper layer (FIL-rich phase). A series of LLE measurements were made 
by changing the temperature of the experiment. The phase diagram determination (both PFC and 
FIL rich side) was accomplished using a temperature controlled bath with a circulator heating 
(Lauda E200 and a cooler Raypa) capable of maintaining the temperature within ± 0.01 K. 
 
 
Figure 3.1 – Binary mixtures for liquid-liquid equilibria: (a) perfluorodecalin + [EtMepy][(PFBu)SO3] and 
(b) perfluorooctane + [HexMeIm][(PFBu)SO3]. 
 
The solubility of fluorinated ionic liquids in PFC-rich phase was determined by synthetic 
method (visual method) because the value of the solubility is very small and no quantitative 
method (analytical method) can determine the tie-line composition. These liquid-liquid phase 
equilibrium measurements were carried out at a atmospheric pressure using a method based on the 
visual detection of the turbidity of the binary mixtures contained in 5 ml Pyrex glass cells 
equipped with magnetic stirrers. The initial solutions were prepared directly inside the 5ml Pyrex 
glass cells equipped with magnetic stirrers by syringing known amounts of each component, 
which were previously weighted using an analytical high-precision balance with a precision of 
±10-5 g. The cell was initially immersed in a thermostatic bath and the sample was continuously 
stirred until two clear phases were observed. Then, the temperature was slowly raised until  the 
last sign of turbidity disappeared. This temperature was taken as the temperature of the liquid-
liquid phase transition. The temperature was measured using a platinum resistance thermometer 
FIL-rich phase 
PFC-rich phase 
a) b) 
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coupled to a Keithley 199 System DMM/Scanner. The overall temperature uncertainty of these 
visual determinations is obviously higher than that measured by the Pt100 and is estimated to be 
±0.5 K. The estimated uncertainty in the mixtures composition is of 0.0001 in mass fraction. 
Water + ethylene glycol mixture were used as the thermostatic fluids, depending on the 
temperature range. 
 
 
 
 
Figure 3.2 – Experimental assembly used to measure solubility of fluorinated ionic liquid 
in PFC-rich. 
 
The temperature was monitored using a four-wire platinum resistance Pt100 thermometer 
coupled to Keithley multimeter with an uncertainty of 0.01 K. This Pt100 thermometer was 
calibrated against high accuracy mercury thermometers (0.01K precision). 
 
3.2.2.2 Analytical Method – Refratometry 
 
As mentioned before only the compositions of the perfluorocarbon in FIL-rich phase were 
determined by measuring the refractive index. For that purpose, an automatic refractometer 
ABBEMAT 500 Anton Paar with a resolution of ± 10-6 and the uncertainty in the experimental 
measurements of ±4·10-5 was used. Calibration curves (Appendix B) were made by measuring the 
refractive index of the samples with known composition at T = 343.15 K. The samples were 
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prepared by filling glass vials with binary mixtures of FIL with perfluorocarbon of known 
composition, determined using a high-precision balance with a precision of ± 10-5 g . The vials 
were closed with screw caps to ensure a secure seal and to prevent humidity. A sample was taken 
from the vial with a syringe through a silicone septum and was immediately put into the 
apparatus. The estimated uncertainty in the composition of the calibration curve is of ± 10-4 in 
mole fraction and in the determination of the phase diagram 0.001 in mole fraction. 
 
Method Validation 
 
In order to validate the quantitative method (refractometry) described above, binary mixtures 
of [BuMeIm][NTf2] + water were studied and compared with literature values [105]. The water 
used was double distilled, passed by a reverse osmosis system, and further treated with a Milli-Q 
Plus 185 water purification apparatus. In the water rich-phase, the phase composition was 
determined by the measurement of the refractive index and the application of the corresponding 
fitting polynomials. In order to provide a more complete work, and thus a better description of 
this system the IL rich-phase was also analyzed, and the phase composition was determined using 
a Metrohm 831 Karl Fisher coulometer (Figure 2.1). IL-rich phase samples of about 0.1 to 0.2 g 
where taken from the equilibrium vials using a glass syringe maintained in dry and warm 
conditions. The liquid-liquid phase diagram of water with [BuMeIm][NTf2] measure in this work 
is represented in Figure 3.3 and compared with literature data [95]. A good agreement with 
literature [105] was achieved. The mole fraction solubility values determined using this 
quantitative method are reported in Table 3.2. 
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Figure 3.3 - Liquid-liquid phase diagram for water (2) and [BuMeIm] [NTf2] (1) and comparison between 
values obtained and values from literature [105].  
 
Table 3.2 - Experimental liquid-liquid equilibria data for binary mixture [BuMeIm] [NTf2] + water as 
function of temperature and comparison with the values from the literature [105]. 
  [BuMeIm] [NTf2] (1) + Water (2) 
 Experimental Literature  Experimental Literature  
T/ K x𝟏IL x𝟏IL Error 
(%) 
x𝟐𝐖𝐚𝐭𝐞𝐫 x𝟐𝐖𝐚𝐭𝐞𝐫 Error(%) 
293.15 0.7591 0.7557 0.321 0.99973 0.99971 0.002 
303.15 0.7207 0.7285 0.764 0.99970 0.99968 0.001 
313.15 0.6826 0.7011 1.486 0.99966 0.99961 0.004 
IL = Ionic Liquid rich-phase 
Water = Water rich-phase 
 
 
3.3 Results and Discussion 
 
In this section, the liquid-liquid phase equilibria will be presented for the following binary 
mixtures: perfluorodecalin + [NBu4][(PFOc)SO3], perfluorooctane + [NBu4][(PFOc)SO3], 
perfluorodecalin + [NBu4][(PFBu)SO3], perfluorooctane + [NBu4][(PFBu)SO3], perfluorodecalin 
+ [HexMeIm][(PFBu)SO3], perfluorooctane + [HexMeIm][(PFBu)SO3], perfluorodecalin + 
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[OcMeIm][(PFBu)SO3], perfluorooctane + [OcMeIm][(PFBu)SO3] and perfluorodecalin + 
[EtMepy][(PFBu)SO3]. 
 
3.3.1 Liquid-Liquid Equilibria of PFCs and [NBu4][(PFOc)SO3] 
 
Experimental data measured for perfluorodecalin and perfluorooctane with 
[NBu4][(PFOc)SO3] are presented in Table 3.3. 
 
Table 3.3 – Experimental liquid-liquid equilibria data for binary mixture perfluorocarbon with 
[NBu4][(PFOc)SO3]. 
Perfluorodecalin(1) + [NBu4][(PFOc)SO3](2) Perfluorooctane(1) + [NBu4][(PFOc)SO3](2) 
T/ K x𝟐PFCa x𝟐𝐅𝐈𝐋 T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 
308.15 − 0.8040 308.15 − 0.7529 
313.15 − 0.7820 313.15 − 0.7462 
318.15 − 0.7531 318.15 − 0.7344 
323.15 − 0.7323 323.15 − 0.7301 
328.15 − 0.7138 328.15 − 0.7244 
333.15 − 0.6963 333.15 − 0.7181 
338.15 − 0.6861 335.67 0.0005 − 
343.15 − 0.6804 338.15 − 0.7114 
344.90 0.0005 − 343.15 − 0.7100 
PFC = Perfluorocarbon rich-phase 
FIL = Fluorinated ionic liquid rich-phase 
a only one value as was explained in the procedure 
 
 
Figure 3.4 illustrates the liquid-liquid equilibrium behaviour of binary mixture of the 
perfluorocarbons studied in this work with [NBu4][(PFOc)SO3]. The typical liquid-liquid 
equilibria behaviour of increasing miscibility with the temperature was observed, although the 
influence of the temperature is small. Another interesting point is that the solubility of the 
[NBu4][(PFOc)SO3] in PFC rich-phase is very close to x2 = 0 (pure perfluorocarbon) in both 
binary mixtures, while a larger solubility (and similar) of both PFC in [NBu4][(PFOc)SO3] was 
found. Nevertheless, perfluorooctane has larger solubility in FIL than perfluorodecalin until T = 
323.15 K. Above this temperature, the behaviour is reversed. 
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Figure 3.4 - Liquid-liquid phase diagram for perfluorodecalin + [NBu4][(PFOc)SO3] and for  
perfluorooctane + [NBu4][(PFOc)SO3]. 
 
3.3.2 Liquid-Liquid Equilibria of PFCs and [NBu4][(PFBu)SO3]  
 
Experimental data measured for perfluorodecalin and perfluorooctane with 
[NBu4][(PFBu)SO3] and perfluorooctane with [NBu4][(PFBu)SO3] are presented in Table 3.4. 
 
Table 3.4 – Experimental liquid-liquid equilibria data for binary mixture perfluorocarbon with 
[NBu4][(PFBu)SO3]. 
Perfluorodecalin(1) + [NBu4][(PFBu)SO3](2) Perfluorooctane(1) + [NBu4][(PFBu)SO3](2) 
T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 
323.15 − 0.9207 325.65 − 0.9291 
325.65 − 0.9142 328.15 − 0.9244 
328.15 − 0.9120 333.15 − 0.9219 
330.65 − 0.9094 336.75 0.0058  
333.15 − 0.9015 338.15 − 0.9138 
338.15 − 0.8975 343.15 − 0.9034 
343.15 − 0.8902 − − − 
345.77 0.0003 − − − − 
PFC = Perfluorocarbon rich-phase 
FIL = Fluorinated ionic liquid rich-phase 
a only one value as was explained in the procedure 
Development of New Oxygen Therapeutics using Fluorinated Ionic Liquids 
  76 
 
For the binary mixture perfluorooctane + [NBu4][(PFBu)SO3], only data from 333.15 K 
onwards were measured since [NBu4][(PFBu)SO3] has a melting point of 327.13 K, according to 
Table 2.2. Also, the upper limit of the working temperature is determined by the high vapor 
pressure of perfluorocarbon. 
Figure 3.5 shows the phase behaviour in the binary mixtures perfluorocarbons with 
[NBu4][(PFBu)SO3]. Again, the solubility of the fluorinated ionic liquid in PFC rich-phase is very 
close to x2 = 0. In the FIL rich-phase, the behaviour of the solubilities are similar for both PFCs, 
for all the temperatures. 
 
 
Figure 3.5 - Liquid-liquid phase diagram for perfluorodecalin + [NBu4][(PFBu)SO3] and for  
perfluorooctane + [NBu4][(PFBu)SO3].  
 
3.3.3 Liquid-Liquid Equilibria diagram of PFCs and 
[HexMeIm][(PFBu)SO3] 
 
Experimental data measured for perfluorodecalin and perflurooctane with 
[HexMeIm][(PFBu)SO3] are presented in Table 3.5. 
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Table 3.5 – Experimental liquid-liquid equilibria data for binary mixture perfluorocarbon with 
[HexMeIm][(PFBu)SO3]. 
Perfluorodecalin(1) + [HexMeIm][(PFBu)SO3](2) Perfluorooctane(1) + [HexMeIm][(PFBu)SO3](2) 
T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 
298.15 − 0.9539 298.15 − 0.9510 
303.15 − 0.9538 303.15 − 0.9485 
308.15 − 0.9530 308.15 − 0.9465 
313.15 − 0.9485 313.15 − 0.9460 
318.15 − 0.9495 318.15 − 0.9451 
323.15 − 0.9473 323.15 − 0.9416 
328.15 − 0.9449 328.15 − 0.9407 
333.15 − 0.9421 333.15 − 0.9408 
338.15 − 0.9375 338.15 − 0.9376 
341.87 0.0008 − 343.15 − 0.9361 
343.15 − 0.9360 344.90 0.0008 −	  
PFC = Perfluorocarbon rich-phase 
FIL = Fluorinated ionic liquid rich-phase 
a only one value as wasexplained in the procedure 
 
Experimental phase diagrams of LLE for the binary mixtures of both perfluorocarbons with 
[HexMeIm][(PFBu)SO3] are shown in Figure 3.6. The behaviour of the solubilities is 
extraordinarily similar for both PFCs at all temperatures. Again, the solubility of PFC in 
[HexMeIm][(PFBu)SO3] is several orders of magnitude higher than the solubility of 
[HexMeIm][(PFBu)SO3] in PFC.  
 
Figure 3.6 - Liquid-liquid phase diagram for perfluorodecalin + [HexMeIm][(PFBu)SO3] and for  
perfluorooctane + [HexMeIm][(PFBu)SO3]. 
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3.3.4 Liquid-Liquid Equilibria of PFCs and [OcMeIm][(PFBu)SO3] 
 
Experimental data measured for pefluorodecalin and perfluorooctane with 
[OcMeIm][(PFBu)SO3] are presented in Table 3.6. 
 
Table 3.6 – Experimental liquid-liquid equilibria data for binary mixture perfluorocarbon with 
[OcMeIm][(PFBu)SO3]. 
Perfluorodecalin(1) + [OcMeIm][(PFBu)SO3] (2) Perfluorooctane(1) + [OcMeIm][(PFBu)SO3] (2) 
T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 
298.15 − 0.9361 298.15 − 0.9085 
303.15 − 0.9359 303.15 − 0.9053 
308.15 − 0.9343 308.15  0.8985 
313.15 − 0.9339 313.15  0.8962 
318.15 − 0.9334 318.15  0.8910 
323.15 − 0.9315 323.15 − 0.8886 
328.15 − 0.9312 328.15 − 0.8863 
329.02 0.0012 − 333.15  0.8858 
333.15 − 0.9304 338.15 − 0.8779 
338.15 − 0.9248 343.15 − 0.8745 
343.15 − 0.9194 344.90 0.0008 − 
PFC = Perfluorocarbon rich-phase 
FIL = Fluorinated ionic liquid rich-phase 
a only one value as was explained in the procedure 
 
Experimental liquid-liquid equilibria data for binary mixtures perfluorocarbon with 
[OcMeIm][(PFBu)SO3] are showed in Figure 3.7. Again, the solubility of the 
[OcMeIm][(PFBu)SO3] in PFC rich-phase is very close to pure perfluorocarbon. In the FIL rich-
phase, the solubility for perfluorooctane in fluorinated ionic liquid is higher than for 
perfluorodecalin. 
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Figure 3.7 - Liquid-liquid phase diagram for perfluorodecalin + [OcMeIm][(PFBu)SO3] and for  
perfluorooctane + [OcMeIm][(PFBu)SO3]. 
 
3.3.5 The Liquid-Liquid phase diagram of PFCs and 
[EtMepy][(PFBu)SO3] 
 
The experimental data measured for [EtMepy][(PFBu)SO3] with perfluorodecalin are 
presented in Table 3.7. The equilibrium liquid-liquid for perfluorooctane with 
[EtMepy][(PFBu)SO3] is not presented here because no reliable data could be obtained for this 
systems, since 72 h were not enough for the equilibrium to be achieved. 
 
Table 3.7 – Experimental liquid-liquid equilibria data for binary mixture perfluorocarbon with 
[EtMepy][(PFBu)SO3]. 
Perfluorodecalin (1) + [EtMepy][(PFBu)SO3] (2) 
T/ K x𝟐PFC a x𝟐𝐅𝐈𝐋 
293.15 − 0.9667 
298.15 − 0.9638 
303.15 − 0.9638 
308.15 − 0.9622 
313.15 − 0.9613 
318.15 − 0.9609 
323.15 − 0.9599 
328.15 − 0.9591 
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332.69 0.0022 − 
333.15 − 0.9584 
338.15 − 0.9592 
343.15 − 0.9584 
PFC = Perfluorocarbon rich-phase 
FIL = Fluorinated ionic liquid rich-phase 
a only one value as was explained in the procedure 
 
3.3.6 Comparisons of the Liquid-Liquid Phase Diagrams of 
Perfluorocarbons and FILs 
 
All the liquid-liquid phase equilibria experimental data measured for perfluorodecalin and 
perfluorooctane with FILs are summarized and compared in Figure 3.8. 
 
Comparing the experimental LLE data for the binary mixtures perfluorodecalin with 
fluorinated ionic liquids, it can be observed that the solubility of perfluorodecalin in FIL increases 
accordingly to the sequence: 
 
[EtMepy][(PFBu)SO3] < [HexMeIm][(PFBu)SO3] ≈ [OcMeIm][(PFBu)SO3] < 
[NBu4][(PFBu)SO3] < [NBu4][(PFOc)SO3] 
 
The same comparison was carried out for the binary mixtures with perfluorooctane and the 
solubility of perfluoroctane in FIL increases accordingly to the sequence: 
 
 [HexMeIm][(PFBu)SO3] < [NBu4][(PFBu)SO3] < [OcMeIm][(PFBu)SO3] < [NBu4][(PFOc)SO3] 
 
Taking into account the results obtained it can be concluded that: 
In the case of perfluorodecalin: PFCs solubility increases from pyrrolidinium to 
imidazolium to the tetralkylammonium for FILs with the same anion, [(PFBu)SO3] ˉ; and the 
increment of the alkyl chain length in the cation has no effect on the solubility.  
In the case of perfluorooctane: the alkyl chain length of the cation influences its solubility 
in FILs.  
For both PFCs was observed that for the same cation, [NBu4]+, an increase in the 
fluorinated chain of the anion, increases the PFC solubility. 
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Figure 3.8 - The liquid-liquid phase diagram of: a) perfluorodecalin and fluorinated ionic liquids and b) 
perfluorooctane and fluorinated ionic liquids.  
 
3.3.7 Correlation of LLE 
 
In this work, the NRTL (Non Random Two Liquid) equation [106] with temperature 
dependent interaction parameters was used to correlate the experimental binary LLE data. In 
general terms, the excess Gibbs energy for the binary mixtures of the correlative equation is 
expressed by the following equations: 
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∆GE
RT
= x1x2 τ21G21x1  + x2G21 + τ12G12x2  + x1G12  (3.3) 
G12 = exp −α12τ21 ,    where 𝛼12 = 𝛼!" = 𝛼 (3.4) 
τ12 = Δg12RT     and      τ21 = Δg21RT  (3.5) 
Δg12 = 𝑎12 + b12 ∙ T    and    Δg21 = 𝑎21 + b21 ∙ T (3.6) 
 
where x is the mole fraction, T is the temperature, α is the non randomness parameter, and τ12 and 
τ21 are the interaction parameters. In this work, all parameters were optimized. The SOLVER 
function in Microsoft Excel was used to adjust these five parameters so that the objective function 
was minimized, providing the set of temperature-dependent adjustable parameters for the binary 
systems. The objective function is defined as follows: 
 
Objective function = 𝑥!!,exp − 𝑥!!,calc !!!!!  (3.7) 
 
The calculated values of the equations are presented in Table 3.8. The standard deviation of 
the mole fraction and the temperature dependence of the correlative parameters are also listed in 
Table 3.8.  
These deviations were calculated by applying the following expression for the binary 
mixtures: 
 
𝜎 = 𝑥!!,exp − 𝑥!!,calc𝑥!!,exp
!!
!!!
!.!
 
(3.8) 
 
where x is the mole fraction and the subscripts i and l provide a designation for the component 
and the phase, respectively. 
 
The fitting curves are shown in Figures 3.5-3.11. These figures show that the NRTL 
equation satisfactorily correlates LLE of the investigated binary mixtures. 
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Table 3.8 – Parameters of the NRTL equations for the binary mixture. 
PFC 𝒂12  
(J mol-1) 
𝒂21  
(J mol-1) 
𝒃12  
(J mol-1 K-1) 
𝒃𝟐𝟏  
(J mol-1 K-1) 
α 𝝈 
[NBu4][(PFOc)SO3] 
Perfluorodecalin 24989.78 20999.93 1.57 - 43.93 0.30 2.64 
Perfluorooctane 24989.78 20999.93 1.77 -44.75 0.30 2.65 
 [NBu4][(PFBu)SO3] 
Perfluorodecalin 24989.78 20999.88 -0.39 -50.05 0.22 1.75 
Perfluorooctane 24989.78 20999.88 -0.39 -50.05 0.21 1.97 
 [HexMeIm][(PFBu)SO3] 
Perfluorodecalin 24989.82 20999.84 -22.77 -28.01 0.40 0.69 
Perfluorooctane 24989.82 20999.83 -22.32 -29.48 0.40 0.47 
 [OcMeIm][(PFBu)SO3] 
Perfluorodecalin 24989.81 20999.83 -26.30 -33.32 0.39 2.58 
Perfluorooctane 24989.81 20999.82 -25.06 -37.04 0.38 1.21 
 [EtMepy][(PFBu)SO3] 
Perfluorodecalin 24989.80 20999.85 -27.96 -27.10 0.42 0.20 
 
3.3.8 Thermodynamic Functions 
 
The change of the standard Gibbs energy is defined by: 
 
∆G=∆H − 𝑇∆S (3.9) 
Where G represents the Gibbs energy, H the enthalpy and S the entropy. 
The dissolution of liquid into another liquid is governed by thermodynamic energies 
involved, namely, standard molar Gibbs energy (∆solGm
0 ), standard molar enthalpy (∆solHm0 ) and 
standard molar entropy (∆solSm
0 ) of solution. The thermodynamic functions describe the solvation 
process that is the process of attraction and association of molecules of a solvent with molecules 
of a solute. These thermodynamic functions can be obtained directly or from the temperature 
dependence of the experimental solute solubility values [107, 108]. These parameters picture the 
transference of one molecule of solute  to a hypothetical dilute ideal solution where the mole 
fraction of the solvent is equal to one, and can be calculated according to the following equations: 
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∆solHm
0 (𝑇)
RT2
= 𝜕 ln 𝑥!𝜕T ! (3.10) 
∆solGm
0 (𝑇) = ln(xi)! (3.11) 
∆solSm
0 (𝑇) = R 𝜕 ln 𝑥!𝜕T ∙ 𝑇 + ln xi ! (3.12) 
 
where xi is the mole fraction solubility of the solute i, R is the ideal gas constant, and T is the 
temperature at a constant pressure, p. 
 
The conventional standard molar enthalpy, Gibs energy and entropy of solution were 
determined for several temperatures, and are represented in Table 3.9. The values at 298.15 K 
were obtained using NRTL equation for the binary systems where the liquid-liquid equilibrium 
data has not been experimentally measured. 
 
The molar enthalpies of solution of the studied PFCs in FILs, between 298.15 and 343.15 
K, show that the solubilisation of the PFCs in FILs based on the ammonium cation, 
[NBu4][(PFOc)SO3] and in [NBu4][(PFBu)SO3], is an endothermic process. However, in the case 
of [HexMeIm][(PFBu)SO3], [OcMeIm][(PFBu)SO3] and [EtMepy][(PFBu)SO3] the processes of 
solubilisation are exothermic. A decrease in the standard molar enthalpy of solution indicates that 
less energy is necessary to promote the dissolution of PFC in fluorinated ionic liquids. Through 
comparison between [HexMeIm][(PFBu)SO3] and [OcMeIm][(PFBu)SO3] is possible to see that 
the alkyl chain in imidazolium cation slightly influences the results. A negative enthalpy of 
solution means that the solute is less soluble at high temperatures. 
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Table 3.9 – Thermodynamic conventional properties of solution of PFCs in FILs studied. 
T/ K ∆solGm
0 (𝑻) 
(kJ mol-1) 
∆solHm0 𝑻  
(kJ mol-1) 
∆solSm0 (𝑻) 
(J K-1 mol-1) 
𝑻∆solSm0 (𝑻) 
(kJ mol-1) 
Perfluorodecalin + [NBu4][(PFOc)SO3]  
298.15 4.25 10.26 20.16 6.01 
308.15 4.17 10.96 22.01 6.78 
313.15 3.97 11.32 23.47 7.35 
318.15 3.70 11.68 25.08 7.98 
323.15 3.54 12.05 26.33 8.51 
328.15 3.41 12.43 27.46 9.01 
333.15 3.30 12.81 28.53 9.51 
338.15 3.26 13.19 29.39 9.94 
343.15 3.25 13.59 30.11 10.33 
Perfluorooctane + [NBu4][(PFOc)SO3]  
298.15 3.70 3.93 0.78 6.56 
308.15 3.58 4.20 2.02 7.38 
313.15 3.57 4.34 2.46 7.75 
318.15 3.51 4.48 3.06 8.17 
323.15 3.52 4.62 3.41 8.53 
328.15 3.52 4.77 3.81 8.91 
333.15 3.51 4.91 4.22 9.30 
338.15 3.49 5.06 4.63 9.70 
343.15 3.53 5.21 4.89 10.06 
Perfluorodecalin + [NBu4][(PFBu)SO3]  
298.15 8.27 16.34 27.07 8.25 
323.15 6.81 18.93 37.49 12.12 
325.65 6.86 19.22 37.95 12.36 
328.15 6.63 19.52 39.26 12.88 
330.65 6.60 19.81 39.96 13.21 
333.15 6.42 20.12 41.11 13.70 
338.15 6.40 20.72 42.35 14.32 
343.15 6.30 21.34 43.83 15.04 
Perfluorooctane + [NBu4][(PFBu)SO3]  
298.15 7.86 16.11 27.67 8.07 
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T/ K ∆solGm
0 (𝑻) 
(kJ mol-1) 
∆solHm0 𝑻  
(kJ mol-1) 
∆solSm0 (𝑻) 
(J K-1 mol-1) 
𝑻∆solSm0 (𝑻) 
(kJ mol-1) 
325.65 7.17 19.49 37.85 12.33 
328.15 7.04 19.79 38.84 12.75 
333.15 7.06 20.40 40.03 13.34 
338.15 6.89 21.02 41.77 14.12 
343.15 6.67 21.64 43.64 14.97 
Perfluorodecalin + [HexMeIm][(PFBu)SO3]  
298.15 0.12 -0.39 -1.72 -0.51 
303.15 0.12 -0.41 -1.74 -0.53 
308.15 0.12 -0.42 -1.77 -0.55 
313.15 0.14 -0.43 -1.80 -0.56 
318.15 0.14 -0.45 -1.84 -0.59 
323.15 0.15 -0.46 -1.88 -0.61 
328.15 0.15 -0.48 -1.93 -0.63 
333.15 0.17 -0.49 -1.97 -0.65 
338.15 0.18 -0.51 -2.04 -0.68 
343.15 0.19 -0.52 -2.07 -0.70 
298.15 0.12 -0.39 -1.72 -0.51 
303.15 0.12 -0.41 -1.74 -0.53 
Perfluorooctane + [HexMeIm][(PFBu)SO3]  
298.15 0.12 -0.39 -1.71 -0.51 
303.15 0.13 -0.40 -1.76 -0.53 
308.15 0.14 -0.41 -1.79 -0.55 
313.15 0.14 -0.43 -1.82 -0.57 
318.15 0.15 -0.44 -1.85 -0.59 
323.15 0.16 -0.45 -1.90 -0.62 
328.15 0.17 -0.47 -1.93 -0.63 
333.15 0.17 -0.48 -1.95 -0.65 
338.15 0.18 -0.50 -2.00 -0.68 
343.15 0.19 -0.51 -2.04 -0.70 
Perfluorodecalin + [OcMeIm][(PFBu)SO3]  
298.15 0.16 -0.25 -1.38 -0.87 
303.15 0.17 -0.26 -1.40 -0.90 
308.15 0.17 -0.27 -1.43 -0.95 
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T/ K ∆solGm
0 (𝑻) 
(kJ mol-1) 
∆solHm0 𝑻  
(kJ mol-1) 
∆solSm0 (𝑻) 
(J K-1 mol-1) 
𝑻∆solSm0 (𝑻) 
(kJ mol-1) 
313.15 0.18 -0.27 -1.45 -0.98 
318.15 0.18 -0.28 -1.46 -1.02 
323.15 0.19 -0.29 -1.49 -1.06 
328.15 0.19 -0.30 -1.51 -1.09 
333.15 0.20 -0.31 -1.53 -1.12 
338.15 0.22 -0.32 -1.60 -1.18 
343.15 0.24 -0.33 -1.66 -1.22 
298.15 0.16 -0.25 -1.38 -0.87 
303.15 0.17 -0.26 -1.40 -0.90 
Perfluorooctane + [OcMeIm][(PFBu)SO3]  
298.15 0.24 -0.63 -2.92 -0.87 
303.15 0.25 -0.65 -2.98 -0.90 
308.15 0.27 -0.67 -3.08 -0.95 
313.15 0.29 -0.70 -3.14 -0.98 
318.15 0.31 -0.72 -3.22 -1.02 
323.15 0.32 -0.74 -3.28 -1.06 
328.15 0.33 -0.77 -3.34 -1.09 
333.15 0.34 -0.79 -3.38 -1.12 
338.15 0.37 -0.81 -3.49 -1.18 
343.15 0.38 -0.84 -3.55 -1.22 
Perfluorodecalin + [EtMepy][(PFBu)SO3]  
293.15 0.08 -0.13 -0.74 -0.22 
298.15 0.09 -0.14 -0.77 -0.23 
303.15 0.09 -0.14 -0.78 -0.24 
308.15 0.10 -0.15 -0.80 -0.25 
313.15 0.10 -0.15 -0.81 -0.25 
318.15 0.11 -0.16 -0.82 -0.26 
323.15 0.11 -0.16 -0.84 -0.27 
328.15 0.11 -0.17 -0.86 -0.28 
333.15 0.12 -0.17 -0.87 -0.29 
338.15 0.12 -0.18 -0.87 -0.29 
343.15 0.12 -0.18 -0.88 -0.30 
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Furthermore, the standard molar enthalpy of solution, ∆solHm0 (𝑇), can be split into two 
contributions: the standard molar enthalpy of vaporization of the solute, ∆!!Hm0 , and the standard 
molar enthalpy of solvation, ∆svtHm0 (𝑇) [107] as follows: 
 
∆solHm0 𝑇 = ∆svtHm0 𝑇 +   ∆!!Hm0  (3.13) 
 
According to the scale particle theory, solvation processes can be envisaged as taking place 
in two steps at the molecular level: 1. an adequate cavity is opened in the solvent; 2. the single 
solute molecule is then inserted and establishes specific interactions. The enthalpy of solvation 
can help explain why solvation occurs, and besides an amount related to the formation of the 
cavity, is determined by solute–solvent interactions only, whereas the enthalpy of solution is 
determined by the balance of solute–solute and solute–solvent interactions [109].  
The standard molar Gibbs free of solvation, ∆svtGm0 (𝑇), can be derived for a temperature T 
using the hypothetical reference state in the gas phase and at the pressure 𝑝! = 10!  Pa. 
 
∆svtGm
0 𝑇 = ∆solGm0 𝑇 + RT ln p(s2,T)𝑝!  (3.14) 
∆svtSm0 (𝑇) = ∆svtHm0 𝑇 − ∆svtGm0 𝑇T  (3.15) 
 
where p(s2,T) is the vapor pressure of the solute at 298.15 K and has a value of 833.26 Pa for 
perfluorodecalin and 5172.89 Pa for perfluorooctane [110, 111]. The standard molar enthalpy of 
vaporization (∆!!Hm0 ) for perfluorodecalin is 45.4 kJmol-1 and for perfluorooctane is 41.13 kJmol-1, 
both at 298.15 K [112, 113]. 
 
The conventional standard molar enthalpy, Gibs energy and entropy of solvation were 
determined for several temperatures, and are represented in Table 3.10. These low molar 
enthalpies of solution and solvation indicate that the enthalpic energetic balance involved in the 
dissolution and solvation, respectively, of PFC in FIL is favourable. 
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Table 3.10 – Thermodynamic conventional properties of solvation of PFCs in FILs studied at 298.15 K. 
PFC ∆svtGm
0 (𝑻) 
(kJ mol-1) 
∆svtHm0 𝑻  
(kJ mol-1) 
∆svtSm0 (𝑻) 
(J K-1 mol-1) 
𝑻∆svtSm0 (𝑻) 
(kJ mol-1) 
[NBu4][(PFOc)SO3]  
Perfluorodecalin -7.62 -35.14 -92.31 -27.52 
Perfluorooctane -3.64 -37.23 -112.64 -26.97 
 [NBu4][(PFBu)SO3]  
Perfluorodecalin 0.92 -24.82 -86.35 -25.28 
Perfluorooctane -4.01 -29.29 -84.80 -25.75 
 [HexMeIm][(PFBu)SO3]  
Perfluorodecalin -11.75 -45.79 -114.18 -34.33 
Perfluorooctane -7.22 -41.55 -115.14 -34.33 
 [OcMeIm][(PFBu)SO3]  
Perfluorodecalin -11.70 -45.65 -113.85 -34.69 
Perfluorooctane -7.10 -41.79 -116.34 -34.69 
 [EtMepy][(PFBu)SO3]  
Perfluorodecalin -11.78 -45.54 -113.23 -33.76 
 
The thermodynamics functions shown above deal with solvation at a macroscopic level while 
the solvation is a molecular process. Another approach to define a standard state could be based 
on statistical mechanical methods as proposed by Ben-Naim [107]. The changes that occur in the 
solute neighbourhood during the dissolution process at a constant temperature, T, and constant 
pressure, p, with the composition of the system unchanged are represented by the local standard 
Gibbs energy, ∆svtGm
* (𝑇), the molar local standard enthalpy, ∆svtHm* 𝑇 , and the molar local 
standard entropy, ∆svtSm
* 𝑇 , of solvation [107, 114]. These standard thermodynamic functions 
can be related to the conventional thermodynamic functions described in equations 3.13 to 3.15, 
using the following equations: 
 
∆svtGm
* 𝑇 = ∆svtGm0 𝑇 − RT ln RT𝑝!𝑉!,!  (3.16) 
∆svtHm* 𝑇 = ∆svtHm0 𝑇 − RT(𝑇𝛼! − 1) (3.17) 
∆svtSm
* 𝑇 = ∆svt𝑆m0 𝑇 + R ln RT𝑝!𝑉!,! − RT(𝑇𝛼! − 1) (3.18) 
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where 𝑉!,! is the molar volume of the solvent j and 𝛼! is the isobaric thermal expansibility of the 
solvent, derived from experimental density data. This coefficient is directly related to the 
temperature derivative of the density by way of the equation: 
 𝛼! = − 𝜕 ln 𝜌𝜕T ! (3.19) 
 
The Ben-Naim local standard Gibbs energy, enthalpy and entropy changes along with the 
molar volume and the thermal expansion coefficient of the liquids at 298.15 K are reported in 
Table 3.11. The values of molar volume are reported in Table 2.5 and the thermal expansion 
coefficients were calculated from equation 2.1. 
 
Table 3.11 – Thermodynamic local standard properties of the solvation of PFCs in the FILs studied at 
298.15 K. 
PFC	  
𝜶𝐣	  K-­‐1	   ∆svtGm*  
(kJ mol-1) 
∆svtHm*  
(kJ mol-1) 
∆svtSm*  
(J K-1 mol-1) 
T∆svtSm*  
(kJ mol-1) Vm/cm3·mol-1	  
[NBu4][(PFOc)SO3] 
Perfluorodecalin 7.547 · 10-4 -17.00 -33.22 -54.39 -16.22 
Perfluorooctane 562.93 -13.02 -35.30 -74.73 -15.67 
[NBu4][(PFBu)SO3] 
Perfluorodecalin 6.482 · 10-4 -9.08 -22.82 -46.11 -13.28 
Perfluorooctane 439.01 -14.01 -27.29 -44.55 -13.75 
[HexMeIm][(PFBu)SO3] 
Perfluorodecalin 6.840 · 10-4 -22.42 -43.82 -71.78 -21.69 
Perfluorooctane 335.06 -17.89 -39.57 -72.74 -21.69 
[OcMeIm][(PFBu)SO3] 
Perfluorodecalin 6.802 · 10-4 -22.13 -43.67 -72.25 -22.28 
Perfluorooctane 369.49 -17.53 -39.82 -74.74 -22.68 
 [EtMepy][(PFBu)SO3] 
Perfluorodecalin 
6.648 · 10-4 
-22.91 -43.55 -69.23 -20.64 
278.08 
 
The values reported show that under the Ben-Naim local standard conditions, the Gibbs free 
energy of solvation is always negative, thus the solvation process is spontaneous.  
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The Ben-Naim standard enthalpies of solvation show that the solvation is favourable because 
the contribution is mainly enthalpic, although there entropic contribution is still non negligible. 
From these values it can be concluded that the interactions between PFC and FILs exist and that 
they are the main contributers to the spontaneous solvation of these molecules. The following 
order was observed for the local standard molar enthalpies of solvation: 
 
 
[HexMeIm][(PFBu)SO3] ≈ [OcMeIm][(PFBu)SO3] ≈ [EtMepy][(PFBu)SO3] > 
[NBu4][(PFOc)SO3] > [NBu4][(PFBu)SO3] 
 
 
Based on the experimental standard molar or on the local standard enthalpies of solvation, it 
can be observed that the ammonium fluorinated ionic liquids lead to strong enthalpic interactions 
with the PFCs, while the imidazoliums and pyridiniums fluorinated ionic liquids show lower and 
similar values. The decrease of the molar enthalpy of solvation reflects the favourable solute – 
solvent interaction. 
 
 
3.4 Conclusions  
 
The liquid-liquid equilibria for binary mixtures involving fluorinated ionic liquids with two 
different PFCs, perfluorodecalin and perfluorooctane, were determined experimentally from 
293.15 to 343.15 K. The aim of this chapter is to select PFC + FIL binary mixtures with a high 
solubility so that these fluorinated ionic liquids can replace partially the PFCs used as oxygen 
therapeutics, thus enhancing the performance of PFCs artificial blood substitutes. The largest 
solubility of the studied PFCs in the FIL rich-phase was achieved when [NBu4][(PFOc)SO3] was 
used. The solubility values for perfluorodecalin (0.68 in molar fraction) and perfluorooctane (0.71 
in molar fraction) obtained, indicate that this fluorinated ionic liquid can be a good election for 
partially replacing the PFCs used in oxygen therapeutics.  
The standard molar enthalpies of solution are temperature dependent and essentially 
independent of the alkyl chain length of the cation. The molar enthalpies of solution of the studied 
perfluorocarbons in FILs show that the solubilisation of the PFCs in ammonium fluorinated ionic 
liquids are endothermic processes and for other FILs the process of solubilisation is exothermic. 
The Ben-Naim standard enthalpies of solvation show the solvation is favourable because the 
enthalpic contributions are bigger than the entropic contributions.  
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4. Final Remarks 
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Final Remarks 
 95 
4.1 Conclusions 
 
This work is a part of a broader project FCT: PTDC/EQU-FTT/118800/2010 focused on 
the development of a new and improved generation of artificial blood substitutes containing 
fluorinated ionic liquids. The overall objective of this thesis was to evaluate the thermophysical 
properties of some FILs and their liquid-liquid phase equilibria of FILs with PFCs in order to 
evaluate the feasibility of partially replacing PFCs in the emulsions used as suitable oxygen 
carriers. 
The first part of this thesis includes the study of thermophysical properties of the FILs in 
order to compare with those of the PFC used as oxygen therapeutics. Mapping the behaviour of 
thermodynamic and thermophysical properties, it can be concluded that [EtMepy][(PFBu)SO3] is 
a good selection because it has a viscosity and a density similar to that of PFC. However, 
[EtMepy][(PFBu)SO3] presents the lowest value of molar free volume, which might hinder the 
solubility of respiratory gases. 
The second part of this thesis addresses the phase behaviour of the FILs with PFC. The 
feasibility of using FIL for replacing, totally or in part, the PFC present in the emulsions was 
evaluated through the study of the liquid-liquid equilibria of binary mixtures of five fluorinated 
ionic liquids with perfluorodecalin and perfluorooctane. The largest solubility of the studied PFCs 
in the used FILs was achieved when [NBu4][(PFOc)SO3] was used. The solubility values for 
perfluorodecalin and perfluorooctane obtained, indicate that this fluorinated ionic liquid can be a 
good election for partially replacing the PFCs used in oxygen therapeutics. Based on the analysis 
of the thermodynamic functions, it can be concluded that the solvation process is spontaneous, 
since the Gibbs free energy of solvation is always negative. 
 
4.2 Future Work 
 
As future work, it would be interesting to continue the study of new families of fluorinated 
ionic liquids with the aim to fine-tune the properties of fluorinated ionic liquids, which can 
possibly be used in the PFC-based emulsion. 
On the other hand, the next natural step of this work will be the determination of the 
solubilities of fluorinated ionic liquids in water and the liquid-liquid equilibria of the ternary 
mixtures FIL + PFC + water. These studies have a particular interest either from the fundamental 
or from the application point of view, since these data are not available in the literature. Also, 
since there are no accurate thermodynamic models which can be confidently be used to predict 
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the properties or/and phase equilibria of fluorinated compounds these data can be a great help in 
understanding the phase behaviour of these mixtures so that new reliable models can be 
developed. Then the thermophysical and thermodynamic properties, of the most relevant binary 
mixtures of FIL + water or FIL + PFC and of the miscible ternary systems containing FIL + PFC 
+ water will measured in the miscible solubility range. 
The final task will be formulation of emulsions and the evaluation of their stability with 
time and temperature. Besides, the oxygen and carbon dioxide solubility in FILs + water 
emulsions and FIL + PFC + water emulsions will be measured and compared with those PFC + 
water emulsions. The use of serum instead of pure water, that is the presence of salts, will also 
need to be addressed. This information will allow us to conclude about the effect of the addition 
of FILs in the currently used PFC based emulsions. 
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A.1  [(EtPFHex)MeIm][PF6] 
 
 
Figure A.1 – TGA curve for [(EtPFHex)MeIm][PF6]. 
 
 
Figure A.2 – DSC curve for [(EtPFHex)MeIm][PF6]. 
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A.2  [(EtPFHex)BuIm][PF6] 
 
Figure A.3 – TGA curve for [(EtPFHex)BuIm][PF6]. 
 
 
Figure A.4 – DSC curve for [(EtPFHex)BuIm][PF6]. 
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A.3  [NBu4][(PFOc)SO3] 
 
 
Figure A.5 – TGA curve for [NBu4][(PFOc)SO3]. 
 
 
Figure A.6 – DSC curve for [NBu4][(PFOc)SO3]. 
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A.4  [NBu4][(PFBu)SO3] 
 
Figure A.7 – TGA curve for [NBu4][(PFBu)SO3]. 
 
 
Figure A.8 – DSC curve for [NBu4][(PFBu)SO3]. 
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A.5  [HexMeIm][(PFBu)SO3] 
 
 
Figure A.9 – TGA curve for [HexMeIm][(PFBu)SO3]. 
 
 
Figure A.10 – DSC curve for [HexMeIm][(PFBu)SO3]. 
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A.6  [OcMeIm][(PFBu)SO3] 
 
 
Figure A.11 – TGA curve for [OcMeIm][(PFBu)SO3]. 
 
 
Figure A.12 – DSC curve for [OcMeIm][(PFBu)SO3]. 
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A.7  [EtMepy][(PFBu)SO3] 
 
 
Figure A.13 – TGA curve for [EtMepy][(PFBu)SO3]. 
 
 
Figure A.14 – DSC curve for [EtMepy][(PFBu)SO3]. 
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A.8  [BuMepyr][(PFBu)SO3] 
 
 
Figure A.15 – TGA curve for [BuMepyr][(PFBu)SO3]. 
 
 
Figure A.16 – DSC curve for [BuMepyr][(PFBu)SO3]. 
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B.1  Calibration curve for Perfluorodecalin and 
[NBu4][(PFOc)SO3] 
 
In order to determine the amount of perfluorodecalin in [NBu4][(PFOc)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorodecalin were prepared in FIL. Table B.1 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.1 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.1 – Refractive index as function of [NBu4][(PFOc)SO3] molar fraction for binary mixture 
[NBu4][(PFOc)SO3] + perfluorodecalin. 
xFIL nD 
1.0000 1.382800 
0.9649 1.381426 
0.9353 1.380291 
0.9073 1.379659 
0.8773 1.377788 
0.8472 1.376384 
0.8172 1.374936 
0.6990 1.369410 
 
 
Figure B.1 – Calibration curve for perfluorodecalin and [NBu4][(PFOcSO3]. 
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B.2  Calibration curve for Perfluorooctane and 
[NBu4][(PFOc)SO3] 
 
In order to determine the amount of perfluorooctane in [NBu4][(PFOc)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorooctane were prepared in FIL. Table B.2 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.2 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.2 – Refractive index as function of [NBu4][(PFOc)SO3] molar fraction for binary mixture 
[NBu4][(PFOc)SO3] + perfluorooctane. 
xFIL nD 
1.0000 1.382800 
0.9640 1.381487 
0.9310 1.379574 
0.9003 1.377764 
0.7823 1.372527 
0.8567 1.375694 
0.7158 1.367727 
 
 
Figure B.2 - Calibration curve for perfluorooctane and [NBu4][(PFOc)SO3]. 
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B.3  Calibration curve for Perfluorodecalin and 
[NBu4][(PFBu)SO3] 
 
In order to determine the amount of perfluorodecalin in [NBu4][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorodecalin were prepared in FIL. Table B.3 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.3 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.3 – Refractive index as function of [NBu4][(PFBu)SO3] molar fraction for binary mixture 
[NBu4][(PFBu)SO3] + perfluorodecalin. 
xFIL nD 
1.0000 1.403054 
0.9877 1.402483 
0.9764 1.401813 
0.9377 1.399959 
0.9132 1.399181 
0.8950 1.398460 
 
 
 
Figure B.3 - Calibration curve for perfluorodecalin and [NBu4][(PFBu)SO3]. 
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B.4  Calibration curve for Perfluorooctane and 
[NBu4][(PFBu)SO3] 
 
In order to determine the amount of perfluorooctane in [NBu4][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorooctane were prepared in FIL. Table B.4 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.4 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.4 – Refractive index as function of [NBu4][(PFBu)SO3] molar fraction for binary mixture 
[NBu4][(PFBu)SO3] + perfluorooctane. 
xFIL nD 
1.0000 1.403054 
0.9787 1.402079 
0.9647 1.401473 
0.9542 1.401165 
0.9431 1.400788 
0.9309 1.400459 
0.8998 1.399042 
 
 
Figure B.4 - Calibration curve for perfluorooctane and [NBu4][(PFBu)SO3]. 
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B.5  Calibration curve for Perfluorodecalin and 
[HexMeIm][(PFBu)SO3] 
 
In order to determine the amount of perfluorodecalin in [HexMeIm][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorodecalin were prepared in FIL. Table B.5 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.5 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.5 – Refractive index as function of [HexMeIm][(PFBu)SO3] molar fraction for binary mixture 
[HexMeIm][(PFBu)SO3] + perfluorodecalin.  
xFIL nD 
1.0000 1.395954 
0.9914 1.395487 
0.9794 1.394729 
0.9701 1.393931 
0.9613 1.393391 
0.9527 1.392775 
 
 
 
Figure B.5 - Calibration curve for perfluorodecalin and [HexMeIm][(PFBu)SO3]. 
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B.6  Calibration curve for Perfluorooctane and 
[HexMeIm][(PFBu)SO3] 
 
In order to determine the amount of perfluorooctane in [HexMeIm][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorooctane were prepared in FIL. Table B.6 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.6 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.6 – Refractive index as function of [HexMeIm][(PFBu)SO3] molar fraction for binary mixture 
[HexMeIm][(PFBu)SO3] + perfluorooctane. 
xFIL nD 
1.0000 1.395954 
0.9864 1.395451 
0.9690 1.394607 
0.9573 1.394065 
0.9462 1.393626 
0.9349 1.393259 
 
 
Figure B.6 - Calibration curve for perfluorooctane and [HexMeIm][(PFBu)SO3]. 
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B.7  Calibration curve for Perfluorodecalin and 
[OcMeIm][(PFBu)SO3] 
 
In order to determine the amount of perfluorodecalin in [OcMeIm][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorodecalin were prepared in FIL. Table B.7 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.7 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.7 – Refractive index as function of [OcMeIm][(PFBu)SO3] molar fraction for binary mixture 
[OcMeIm][(PFBu)SO3] + perfluorodecalin.  
xFIL nD 
1.000 1.400076 
0.9829 1.399332 
0.9728 1.398825 
0.9659 1.398034 
0.9526 1.397405 
0.9302 1.396136 
0.9154 1.395646 
0.9040 1.395031 
 
 
Figure B.7 - Calibration curve for perfluorodecalin and [OcMeIm][(PFBu)SO3]. 
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B.8  Calibration curve for Perfluorooctane and 
[OcMeIm][(PFBu)SO3] 
 
In order to determine the amount of perfluorooctane in [OcMeIm][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorooctane were prepared in FIL. Table B.8 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.8 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.8 - Refractive index as function of [OcMeIm][(PFBu)SO3] molar fraction for binary mixture 
[OcMeIm][(PFBu)SO3] + perfluorooctane. 
xFIL nD 
1.0000 1.400076 
0.9757 1.399563 
0.9120 1.398680 
0.8786 1.398348 
0.8307 1.397504 
0.8112 1.397298 
 
 
Figure B.8 - Calibration curve for perfluorooctane and [OcMeIm][(PFBu)SO3]. 
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B.9  Calibration curve for Perfluorodecalin and 
[EtMepy][(PFBu)SO3] 
 
In order to determine the amount of perfluorooctane in [EtMepy][(PFBu)SO3] phase, a 
calibration curve was used. For this purpose, solutions of different known concentrations of 
perfluorodecalin were prepared in FIL. Table B.9 presents the concentration of the prepared 
solutions and the refractive index obtained. Figure B.9 presents the linear function obtained and 
respective slope and correlation coefficient. 
 
Table B.9 – Refractive index as function of [EtMepy][(PFBu)SO3] molar fraction for binary mixture 
[EtMepy][(PFBu)SO3] + perfluorodecalin. 
xFIL nD 
1.0000 1.406419 
0.9951 1.405526 
0.9857 1.407133 
0.9844 1.405111 
0.9773 1.405023 
0.9752 1.405491 
0.9732 1.406212 
0.9693 1.405722 
 
 
Figure B.9 - Calibration curve for perfluorodecalin and [EtMepy][(PFBu)SO3]. 
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